Clemson University

TigerPrints
All Dissertations

Dissertations

8-2016

Molecular Mechanics Studies of Protein Signaling
and Conformation Change
Zhe Jia
Clemson University

Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations
Recommended Citation
Jia, Zhe, "Molecular Mechanics Studies of Protein Signaling and Conformation Change" (2016). All Dissertations. 1727.
https://tigerprints.clemson.edu/all_dissertations/1727

This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by
an authorized administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.

MOLECULAR MECHANICS STUDIES OF PROTEIN SIGNALING AND
CONFORMATION CHANGE

A Dissertation
Presented to
the Graduate School of
Clemson University

In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
Chemistry

by
Zhe Jia
August 2016

Accepted by:
Dr. Brian Dominy, Committee Chair
Dr. Steve Stuart
Dr. Emil Alexov
Dr. Julia Brumaghim

ABSTRACT
Physiology signals can be passed by proteins. Many protein signaling starts from ligand
binding and undergoes conformation change of the receptors. Many cellular surface
receptor proteins contain a Von Willebrand factor (vWF), which is a large multimeric
glycoprotein present in blood plasma. This dissertation employed molecular dynamics
(MD) simulation to investigate the binding and signaling process of several vWF type A
proteins.

Chapter 2 discussed the potential errors modeling and MD sampling methods, and
evaluated the accuracy and precision of free energy calculation. An optimized sampling
strategy was established to obtain the best computational efficiency. The strategy can be
applied to a wide range of protein binding research.

The following chapters investigated the binding and signaling process of anthrax
receptors and integrins, which are vWF type A proteins. Binding mechanism, possibility
of conformational change, and the role of metal ion in binding process, were analyzed
and compared for two structurally highly similar anthrax receptor proteins, tumor
endothelial marker 8 (TEM8) and capillary morphogenesis gene 2 (CMG2). The two
highly similar proteins are the drug target for distinct diseases. The differences in these
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two processes were found can guide the further development of drug specifically
targeting one of the proteins. A conformation change between open and closed
conformation is known to exist in most vWF type A proteins, but has not been
experimentally observed in the anthrax receptors. Chapter 5 investigated the binding and
conformation change process of integrins using targeted molecular dynamics simulation,
and compared with anthrax receptors. The key residues and correlated motions in
conformation change process were revealed, which can serve as a reference to the
development in small molecule inhibitors of the signaling process. Results further
confirmed the difficulties of observing conformation change in anthrax receptors.
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CHAPTER 1

INTRODUCTION

Molecular Mechanics Generalized Born Surface Area method is widely used to estimate
the binding free energy of protein-ligand interaction and recently for protein-protein
interaction. The binding process can be described using the following equation:

where P is the free protein; L is the free ligand; and PL is the protein-ligand complex. In
this dissertation, I will first evaluate the energy calculation method, and followed by
some applications on the protein-protein binding and protein conformation change I have
mainly studied. For instance, in protein-protein complexes, the dissociation constant Kd
of Equation 1.1 is measured experimentally using Surface Plasmon Resonance,

The dissociation constant can be further correlated to ΔG, the binding free energy,

where R,T and C0 are the gas constant, temperature in Kelvin and the standard
concentration, respectively. Through this dissertation, ΔG will be used as a general
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notation of free energy, for both Gibbs free energy and Helmholtz free energy (Equation
1.3). In this dissertation, constant pressure and temperature are used in protein simulation,
as in most condensed system simulation conditions. Thus the pressure volume term in
Equation 1.3 is negligible, which should be added for a correct definition of Gibbs free
energy 1.

1.1 Thermodynamics basis of protein-ligand binding
The dissociation constant Kd can also be explained by a modern statistical form shown by
Sharp2 and Roux3. When ligand (L) molecules are bound to protein (P) molecules, p1 is
the probability of one of the ligand molecules is bound to one of the protein molecules.
Conversely, the probability of this ligand molecule is unbound is defined as p0. And p0 +
p1 = 1. Thus, if we define the total protein concentration in the system is [P]tot , then the
unbound protein concentration [P] = p0[P]tot, and the concentration of protein-ligand
complex [PL] = p1[P]tot. Hence,

A configurational average is needed to calculate the probabilities. Considering an
operator H that gives value 1 for the bound state, and 0 otherwise. The configurational
space can be separated into bound and unbound (bulk). Further, p0 and p1 can be
2

expressed as

and

where dq is the coordinate of one of the ligands, dS is the coordinate of the surroundings,
β≡1/RT, and U is the total potential energy. Now, Kd can be written as

where the indistinguishable ligands are summed up to N. If we assume the bulk part is
isotropic and homogenous, the deviation can be further taken to

where V is the volume of the bulk, δ is the Dirac delta function, r1-r* is the distance
between the ligand molecule and some arbitrary position in the bulk. The last equality can
be performed if we allow [L] = N/V. Equation 1.8 implies that the ratio of the likelihood
in bound state to the ratio of likelihood in bulk state is legit to represent Kd. It gives the
components we need to calculate to obtain the binding free energy.

3

Based on Equation 1.8, there are three main components: U, the total potential energy of
the complex; the configurational integrals and the free energy. Unfortunately, the free
energy cannot be evaluated from Equation 1.8 in practice, because it is not practical to
sample all possible configurations in a bulk system. Therefore, we need to simplify the
equation by making assumptions such that it can be computed. Chapter 2 will focus on
evaluating MM/GBSA method to estimate the binding free energy in protein-protein
complex.

1.2 Anthrax and protective antigen

Anthrax is a disease known to affect herbivorous animals, such as sheep, cows, goats, and
horses. The disease was extremely rare in humans and was not paid much attention to,
until 2001, it was used as a bioterrorism weapon resulting in the deaths of 5 people. The
attack reinstates the interest in anthrax research4-6. I employed computational methods
modeled and analyzed the binding mechanism of anthrax toxin (Chapter 3 and 4). The
free energy estimation methods were examined using anthrax related proteins in Chapter
2.

Anthrax is caused by an organism called Bacillus anthracis. Although studies have shown
4

bacterial titer in the bloodstream as high as 109 bacteria per mL can be eliminated within
hours; once the bacteria appear in the blood, treatment must be initiated within 48 hours.
Bacteria can still be killed after 48 hours of the infection, but enough anthrax toxin will
remain to be fatal4,5. Another important characteristic of Bacillus anthracis is that it is a
spore forming organism. The spore is able to survive extremely harsh conditions. The
survival time can be up to several decades7. In connection with bacterial weapon, this is
the most significant attribute of the bacterium. A massive attach using anthrax spores
would result in the inhalation and infection of such a large number of people that ample
supply and administration of a drug would be very unlikely within 48-hour period.

Bacillus anthracis, is a large rod-shaped, Gram-positive, soil bacterium. The two
virulence factors are the capsule and the anthrax toxin8. The major cause of death in
anthrax is the 3-protein toxin that the bacterium secretes. The three anthrax proteins are
designated protective antigen (PA), edema factor (EF), and lethal factor (LF)9. PA is
nontoxic, but it is responsible for the delivery of the two toxic proteins, EF and LF, which
disable the normal immune function of the host10,11. PA (83 kDa) binds to one of its two
receptors, following cleavage by a protease, forms a heptamer that is able to bind and
deliver EF and/or LF into the cell

12

. The X-ray crystal structures of protective antigen,

edema factor and lethal factor have all been determined13,14.

5

The four domains of PA monomer (Figure 1.1) are mainly made of antiparallel β-sheets13.
Domain I (residues 1-258) contains two calcium ions and the cleavage site for proteases
to activate the protein. An amino terminal fragment of 20kd is cleaved after the protease
was activated15. Domain II (residues 259-487) participates in the formation of the
heptamer. The flexible loop on domain II (β2-β4) aids in membrane insertion. To date, the
function of Domain III (residues 488-595) is still not formally reported. Domain IV
(residues 596-735) donates the majority of affinity in receptor binding13.

6

Figure 1.1 Structure of protective antigen binding with CMG2. The upper part shows the four-domain
structure of PA83, the lower part shows the VWA domain of CMG2. The four PA domains are colored
separately, domain I in yellow, domain II in red, domain III in tan and domain IV in blue.

7

1.3 Anthrax receptors

Binding to target cells is the entire responsibility of protective antigen. On the surface of
mammalian cells, two anthrax receptors, Tumor endothelial marker 8 (TEM8 or
ANTXR1) and capillary morphogenesis gene 2 protein (CMG2 or ANTXR2) were found.

TEM8 was the first anthrax toxin receptor described. Originally discovered in endothelia
of colon carcinomas by serial analysis of gene expression, TEM8 has been postulated to
be important for tumor angiogenesis16. To date, three splice variants of TEM8 have been
reported: var1 (564 residues), var2 (368 residues), var3 (333 residues), var4 (528
residues), var5 (358 residues). Var1, var2 and var4 are single-pass type-1 integral
membrane proteins, whereas var3 and var5, lacking the transmembrane helices, are
thought to be a secreted form. The anthrax toxin receptor was first identified as the
368-residue variant 217.

The other toxin receptor, CMG2, was first reported in 2001 as a new gene up-regulated
during in vitro capillary morphogenesis18. In 2003, mutations on CMG2 was identified in
infantile systemic hyalinosis and juvenile hyaline fibromatosis patients

19,20

. This protein

exhibited elevated expression during umbilical cord endothelial cell tubulation in
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collagen matrices18. Similar to TEM8, CMG2 also has splice variants: CMG2-488, 489,
386, and 322. The first three are single-pass type-1 integral membrane proteins, and the
last one, CMG2-322 is likely a secreted protein as it lacks the transmembrane helix.
Excluding the last 13 residues, the primary structures of CMG2-488 and CMG2-489 are
identical. CMG2-386 was first formally identified in 200118. In 2003 CMG2-489 was
found to be an anthrax toxin receptor, and it is now known that CMG2-488 is also an
equally good toxin receptor10,21. CMG2-386 differs from CMG2-489 only in that it lacks
the membrane-proximal segment spanning residues 218-318. Otherwise the two
sequences are the same.

Both receptors are type I transmembrane proteins that possess an integrin-like
extracellular I domain. The PA receptors are known to have natural ligands, TEM8
interacts with collagen VI22, and CMG2 interacts with collagen IV and laminin18. Both
receptors share highly similar von Willebrand factor type A (vWA) domain. These
domains that locate in their extracellular N-terminal are 60% identical in amino acid
sequence. The vWA domain binds to PA domains II and IV via its metal ion dependent
adhesion site (MIDAS)23,24. The interaction of binding mimics the recognition of
integrins to the extracellular matrix. Unlike the physiological ligands of vWA domains, a
hydrophobic pocket in the receptor holds an insertion of a loop of PA domain II. Due to

9

the hydrophobic ridge that is built by this insertion, the interaction of PA with its receptor
is at least 10-fold (some have reported about 1000-fold) higher than most other ligands of
vWA domain25.

CMG2 is widely distributed in normal adult tissues (e.g., brain, kidney, lung and muscle).
Otherwise, TEM8 is seldom observed in normal tissues but abundant in the vasculature of
developing embryos and tumor endothelial cells10,22,26. The distribution in normal tissues
makes CMG2 the dominating receptor that responsible for the lethality of anthrax toxin27.
Further, the PA binding affinities of CMG2 and TEM8 differ by an order of magnitude.
The reported affinity of CMG2-PA (Kd=170 pM, ΔGbinding=-56.1 kJ/mol) is much higher
than TEM8-PA (Kd=1.1 μM, ΔGbinding=-34.2k J/mol)

21,24

. (Kd values are collected from

prior experimental works, ΔGbinding are calculated by ΔGbinding=RTlnKd)

A majority of interaction energy comes from the interaction between PA and vWA motif
on receptors. MIDAS site of both receptors bind to PA by attracting an aspartic acid side
chain (D683) from PA that completes the coordination sphere of the MIDAS metal ion25.
Toxicity can be completely removed by mutating the aspartic acid to asparagine 23. There
are two possible conformations for the MIDAS motif in vWA domains: closed state
(low-affinity ligand bound) and open state (high affinity ligand bound)28. Based on the

10

crystal structure of CMG2-PA binding conformation, CMG2 is reported to adopt the open
state, and this open state is considered as a reason that CMG2 has a high affinity towards
PA7,11,25. Mutational analysis suggests that TEM8 also adopts an open state
conformation23 and was later proved by the structure of TEM8 that was obtained in
201029. To date, the structure of TEM8-PA binding state has not been formally reported.

Figure 1.2 Interaction surface between PA and CMG2. Contacting loops are colored red for CMG2. The
green part shows PA domain II inserts into the pocket formed by CMG2. The blue loop interacts with the
ridge on CMG2 surface. All α-carbon atoms of residues on the loops are colored yellow. Mn2+ ion in the
MIDAS domain is colored purple.

Large contact surface between PA and receptors is also responsible for the binding

11

affinity. Comparing to a typical α-integrin-ligand (~1300 Å2)11, 25, CMG2 has a much
larger contact surface (~2000 Å2) with its ligand (PA). The contact surface is mainly
contributed by the buried surface area between PA domain IV and CMG2 residues around
the MIDAS motif. On CMG2, the α2-α3 loops are pushed out from the MIDAS motif and
form an outstanding hydrophobic group that inserts into a hydrophobic pocket formed by
residues on PA IV. PA domain II contributes a smaller part to the buried surface area
between PA and CMG2. On PA II near CMG2, a β-hairpin contains a mixture of
hydrophobic and hydrophilic residues inserts into a pocket formed by CMG2 α6-α7 loop
and α7 helix. More than 600 Å2 is buried by this insertion. According to computational
structural comparison, the insertion and pockets are also found in TEM8. This implies
similar mechanism in the way the two receptors bind to PA.

Although TEM8 and CMG2 are highly identical in sequence, their binding affinities for
PA are not similar. Several residues around the vWA domain of both receptors are
reported to be responsible for this difference. Residues on the MIDAS domain are highly
conserved between TEM8 and CMG2. However, most of the residues on CMG2 contact
interface with PA are not conserved TEM8. Mutational analysis proved that single point
mutations on the non-conserved surface residues significantly change the binding
affinity29. These residues are commonly referred to “hot spots”. The study of these

12

“hotspots” will provide valuable information for designing protein related agents that
target the interaction surface of proteins.

Alanine scanning is the most widely used experimental method for identifying binding
sites and “hotspots”. In recent years, hot spot residues in a protein complex structure can
also be predicted by several computational methods. Once the structure of protein is
available, it is possible to predict the “hotspots” by computational method, and the
efficiency of prediction will be much higher.

Variants of PA and TEM8/CMG2 can be widely used in anthrax or angiogenesis treatment.
Modified anthrax toxins are being developed as potential anti-cancer agents

31,32

.

PA-binding-affinity-elevated mutants of CMG2 or TEM8 could inhibit anthrax
intoxication 33. However, the exact mechanism of how they bind PA with higher affinity
is still not reported. Mutational study of CMG2/TEM8 will find out the important
residue(s) and/or conformation(s) that responsible for the binding interaction, hence
explain the interaction type and figure out the way to make efficient mutations. PA binds
to CMG2 more than 10-fold better than to TEM8. But to serve as a potential anti-cancer
agent, the compound is required to bind tighter to TEM8. After knowing the “hotspots”
and “hot” region(s), it is possible that PA mutants with additional specificity towards

13

CMG2 or “reversed” specificity towards TEM8 could be predicted by mutational study of
PA. Additional PA variants that bind preferentially to either receptor are potential
anti-angiogenesis therapeutic agents target normal tissues or tumor tissues. To obtain the
desired models of mutants, I will make point mutations or group mutations on the
residues of the interaction surface, both hotspots and non-hotspots. Mutations on hotspots
or the highly conserved residues will possibly reduce the binding affinity, whereas,
mutations on non-hotspots residues will likely increase the affinity. The binding
mechanism of PA-TEM8 binding will be investigated in Chapter 3, followed by a
comparison to PA-CMG2 binding in Chapter 4.

14

CHAPTER 2

EVALUATING THE PERFORMANCE OF MM/GBSA METHOD IN ESTIMATING
PROTEIN LIGAND BINDING AFFINITY

ABSTRACT

This chapter evaluated the modeling, simulation and free energy calculation methods
used the following chapters, especially the Molecular Mechanics/ Generalized Born
Surface Area (MM/GBSA) method. This method is widely used to predict protein-ligand
binding affinity, because it is statistically more rigorous than docking and
computationally less expensive than FEP/TI. It gives satisfactory prediction results for
some protein-ligand binding complexes. But for other systems, simulation can show
miserably poor correlation to experiments. The choice of force field, dielectric constant
and other simulation parameters can significantly affect the accuracy of the results. The
validity of MM/GBSA heavily depends on the sampling method. Thus, the length of MD
simulation and number of repeats also play an important role. The chapter evaluated the
performance of MM/GBSA in predicting protein-ligand, protein-protein affinities and
protein folding energies using several microseconds of MD simulation. I found an
anomalous autocorrelation time in energies resulted from the fractal “memory kernel”
15

like behavior of proteins. The location of ligand molecules, flexibility of ligands and
friction parameters have significant impact on the autocorrelation time in energies, thus
affect sampling efficiency. Improper sampling method or insufficient equilibration will
lead to under estimated errors in energies, further, irreproducible results. MM/GBSA can
still serve as a powerful tool in free energy estimation, if the conditions and errors are
properly evaluated. Considering all factors above, this chapter gives a solution to obtain
statistically rigorous MM/GBSA results efficiently at predetermined computing hours.
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2.1 Inroduction

Computer aided drug design (CADD) facilitates and accelerates the identification of new
candidates in early state drug discovery. Once the candidates were discovered using
high-throughput methods like structural based docking based on empirical scoring
function, more accurate low-throughput computational methods are needed to optimize
their chemical features. The calculation of protein-protein and protein-ligand interaction
free energy is one of the most important protocol in these low-throughput methods.
Molecular Mechanics/Poisson Boltzmann Surface Area34 (MM/PBSA) and Molecular
Mechanics/Generalized Born Surface Area35 (MM/GBSA) are two of the commonly used
methods to calculate free energy. Comparing to the statistical mechanically rigorous Free
Energy Perturbation36 (FEP) and Thermodynamics Integration37 (TI) methods,
MM/PBSA and MM/GBSA use reasonable assumptions to improve the computational
efficiency. Furthermore, MM/PBSA and MM/GBSA allow for the rigorous and insightful
free energy decomposition into interaction type and atom group components. The Linear
Interaction Energy38 (LIE) method is related to MM/PBSA and MM/GBSA, but it
requires a large training set to fit the parameters.

There are in fact many approaches to estimate free energy. The main differences are the
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force fields and the Generalized Born models applied. The energies can also be calculated
from an individual energy-minimized conformation or from an ensemble of
conformations extracted from MD/MC simulation trajectories or other sampling methods.
Some energy that is known to deteriorate the method accuracy can be included or
excluded of binding contributions. For all these methods, comparing to structural based
scoring functions such as docking, the physics based methods can provide better
correlation with experimental results and enable more detailed analysis 39-43.

However, the assumptions made in the MM/PBSA and MM/GBSA methods limit the
accuracy and usage of these methods. For each individual system, the accuracy,
efficiency and feasibility vary depending on the size, composition, and research aim. To
investigate the proper application of MM/GBSA method, this chapter starts from a brief
description of the theoretical backgrounds of sampling and free energy calculation
methods, followed by a series of test to access the performance of MM/GBSA method on
one of the Von Willebrand Factor A proteins.
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2.2 Theoretical Background
2.2.1 Molecular Mechanics
The motion of atoms in a system can be described using Newtonian mechanics in
Molecular Mechanics. A force field that composed by some functions and parameters is
employed to describe the potential of the system. In most of the force fields for
biomolecules, many-body effects are approximated using pair-wise potential, although
some many-body effects such as polarization are also included44,45. The functions are
parameters that were differed chiefly in the most common force fields such as
CHARMM46, Amber

47

, OPLS48, and Gromos49, although they are based on different

theories.

Different force fields treat atoms differently. All atoms are calculated in the modern
versions of Amber, CHARMM, and OPLS, whereas the non-polar hydrogen atoms are
merged into the carbon atoms in Gromos. Such lightly modified force fields were very
popular in the 80’s and early 90’s when the computing power was not as efficient as
today. Recent years, these coarse grained force fields are mainly used to simulate long
time scale process such as large protein folding or domain motion.

The molecular potential of CHARMM force field is shown as follows
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where the first five terms are bonded terms that describe the potential energy from bond
stretching, angle bending, dihedral rotation, improper rotation and Urey-Bradley
cross-term accounting for angle bending using 1, 3 nonbonded interactions. And the last
two terms are nonbonded terms describes repulsion, dispersion, and electrostatics. The
Urey-Bradley term is specifically introduced by CHARMM. It is a potential that couples
bond and angles motions to improve the description of the torsions of the protein
backbone46,50.

The first five bond terms are a summation of simple harmonic terms, where the kb, kθ, kφ,
kω, and ku are the force constant; b, θ, φ, ω and u are the actual value; and the
corresponding symbols with “0” subscript are idea values or values at the equilibrium
location.

The non-bonded terms contains a Lennard-Jones potential that describes repultion and
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dispersion, and a Coulomb term that describes the electrostatics. These potential energies
are calculated as pair-wise energies between all pairs of the atoms in the system, with a
few exceptions. First, pairs of bonded atoms are excluded because these interactions are
included in bond and angle terms. Second, pairs of atoms with three bonds in between
(so-called 1-4 interactions) are scaled down because these interactions are partly
described by the torsion term. Thirdly, pairs of atoms that have more than a certain
cut-off distance between them are excluded or treated using a different function.

The Lennard-Jones potential can be expressed in many slightly different forms depending
on the parameter exist in the force field. In all forms, the r-6 term describes the dispersion
in a system which can in principle be derived from dispersion theory51; the r-12 term
describes the repulsion which is chosen for computational convenience52. The repulsion
term, physically, can be better described by an exponential term, but with decreased
computational efficiency.

The Coulomb potential is described using the partial charges qi, qj of the two atoms i, j
(Equation 2.1), where ε is the dielectric constant of the media. Comparing to
Lennard-Jones potential, the electrostatic energy doesn’t decay as fast. Plus, the
electrostatic interactions are very important for correct energies and therefore they are
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always required to be treated rather accurately even beyond the cut-off distance. In the
practice of protein simulation using periodic boundary, the electrostatics are most
commonly replaced by a Ewald summation that treats the long-range interaction in
reciprocal space using fast Fourier transform52,53.

2.2.2 Implicit Solvent Models
Implicit solvent models, by their name, treat the solvent molecules implicitly, and this is
one of the most common methods to reduce the complexity of the system. The most
popular approach is the treat the solvent as a dielectric continuum, which originates from
the work of Max Born54. In this approach, there are two phases in the solvation process.
First, it creates a cavity in the solvent that can tightly accommodate the solute. Second, it
introduces the solute into the cavity and turns on the interactions between solute and
solvent. The solvation free energy can be expressed by

where Gcav is the free energy of creating the cavity in the solvent, and the next three terms
are the repulsion, dispersion, and electrostatics interaction energies. Other than the first
term on the right hand side of Equation 2.2, the other terms on the right are written as
energies rather than free energies. This stems from an assumption that the solvent
structure is not perturbed by the introduction of solvent-solute interactions. The
22

assumption works decently for the repulsion and dispersion terms, but not usually for the
electrostatic term55. In most continuum solvent models, a non-polar term, Gnp, takes the
first three terms on the right side of Equation 2.2; and a polar term. Gpol, takes the
electrostatics, such that

The most popular method to estimate the non-polar solvation free energy is based on the
solvent accessible surface area (SASA)56. It assumes a linear relationship between the
loss in SASA and binding free energy.

where γ is an empirical parameter in the unit of surface tension, b is an empirical constant.
The parameters are fitted to experimental solvation free energies of hydrocarbons57.

The treatment of polar solvation energy starts from considering the Poisson equation for
the solvent58

where ε is the dielectric constant, φ is the electrostatic potential, and ρ is the charge
density. If ionic strength is considered, an extra Boltzmann factor can be added into
Equation 2.5, and results in the Poisson-Boltzmann (PB) equation. This is not common in
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biomolecular simulations59, but approaches based on Equation 2.5 are still refered to PB
methods. In most practices, the equation is solved using the finite difference method that
distributes the charge distribution and dielectric constant on a grid.

The solvation free energy can be obtained from calculating the reaction field of the
system. The reaction field, φreact, is the difference in potentials under the dielectric
constant of the actual solvent and the dielectric constant of vacuum, for which 80 and 1
are commonly selected to best reproduce experiment results. The reaction field can be
further represented by a set of point charges as in a force field 60 by

This equation can be reduced in the case of a single ion of radius a in pure solvent, which
is called the Born formula

where εsolv is the dielectric constant of the solvent.

The generalized Born (GB) model generalizes Equation 2.7 by mapping atoms to spheres
with charges and radii. When the distance between two atoms is larger than their radii,
Equation 2.6 can be derived into a summation of individual Born terms and pair-wise
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Coulomb terms61.

If we use symbol fGB as an approximation function of the distance between atoms and
their effective Born radii, Equation 2.7 can be further reduced to

Among the distinct flavors of GB methods, fGB is approximated following difference
theories61.

2.2.3 Molecular Dynamics Sampling Method
Molecular dynamics employs Newton’s second law62 to iterate the system over time.
Each particle i in the system has a mass of mi and a coordinate qi. The force on particle i
can be expressed as

The force can be calculated from the gradient of force field (potential) using

The coordinate after a finite time step, Δt, can be calculated using a simple Taylor
expansion
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At time t, if the coordinate q(t), the velocity dq(t)/dt, and the acceleration d2q(t)/dt2
(Equation 2.10) are known, the system can be propagated to the next time step t+Δt. The
higher order terms are approximated or omitted.

At the beginning of a Molecular Dynamics simulation, the coordinates and velocities are
initialized for all particles in the system. For each consecutive step afterwards, the forces,
velocities, and coordinates are updated for each particle based on the force field. There
exist numerous algorithms for updating these parameters, such as simple Verlet63,
leapfrog64, and velocity Verlet algorithms65.

The time step of iteration should be small enough to cover all the motions in the system,
e.g. the fastest motion in biomolecular system is the vibration period of the bonds involve
lightest weight atom, hydrogen, which is ~10fs. As a rule of thumb, the time step should
be about a tenth of the period of the fastest motion, 1fs. However, the vibration of
hydrogen involved bonds is not always valuable to the research, and can sometimes be
omitted to increase simulation efficiency. SHAKE66 is one of algorithms that perform a
restraint on bonds involving hydrogen atoms. Once these bonds are restrained, the time
step can usually be increased from 1fs to 2fs, to increase the simulation efficiency.
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An ensemble of conformations can be collected from an MD simulation. These
conformations have different microscopic states, but belong to the same macroscopic or
thermodynamic state. In this dissertation, all MD simulations were performed to compare
with experimental results at constant pressure and temperature. To keep these parameters
comparable in this dissertation, simulations were conducted using constant number of
particles, volume, and pressure. Such systems are known as isobaric-isothermal
ensembles.

To keep the temperature constant in Molecular Dynamics simulation, an thermostat
algorithm67 is used. All simulations in this dissertation employed a Langevin thermostat68.
Thus, Langevin dynamics were performed rather than Newtonian dynamics. Comparing
to Newtonian dynamics, a velocity related friction term dq/dt and a random force term
R(t) are introduced.

The Langevin piston69 method is used as a barostat to maintain the constant pressure.

In protein binding research, the system can sometimes be very large, but the interesting
chemistry only occurs in a small region. A well designed truncation of the protein can
increase the simulation efficiency without losing the dynamic details (see 2.4.2).
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2.2.4 Sampling Strategy
One most important property of good simulation is being able to reconstruct the
prescribed distribution, which, in this dissertation, is a Boltzmann distribution for
canonical ensemble70. For some quantity A, the average of A can be calculated by
averaging the N samples extracted from the simulation as

The precision of this average can be described using the variance. The variance is only
valid when the N samples are independent of each other71. One approach to measure the
independency of the samples is to use the autocorrelation function (ACF). A correlation
time

can be calculated from ACF and be further used to measure the simulation time

takes to eliminate the correlation to previous conformations. Once

is known, the

interval between consecutive samples can be determined. Statistical inefficiency can also
be estimated based on a given

72,73

.

In practice, the dynamics of proteins consists a property similar to memory kernel 74,75.
The autocorrelation time is sensitive to protein properties such as location of domains,
and the location of the binding site. Therefore, an accurate estimation of
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can be very

challenging. An alternative and effective solution to obtain independent samples is to
conduct M independent repeat calculations for a system. The average of property A can
be calculated by

where N’ is the number of samples in each repeat. In ideal perfect sample from infinitely
long simulation, the ensemble average of property A calculated from Equation 2.14 and
2.15 should be identical. However, the precisions of A calculated from Equation 2.14 and
2.15 are not identical. The formal one is inversely proportional to
on is inversely proportional to

, whereas the latter

.

Independent repeats of simulations are commonly generated by simply assigning
different starting velocities to start the simulation76-78. Since none of the coordinates of
initial conformation are changed, the perturbation to the system can be considered as
fairly small.

2.2.5 MM/PBSA and MM/GBSA methods
In MM/GBSA and MM/PBSA methods, the binding free energy between the ligand and
the receptor can be calculated using the following equation:
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where ΔGbind is the total binding free energy, EMM is the Molecular Mechanics energy,
ΔGsol is the solvation free energy, Eint is the internal strength energy, Eelec is the
Coulombic interaction energy, EvDW is the van der Waals interaction energy, GGB is the
generalized Born free energy, ESASA is the solvent accessible surface area interaction
energy, Strans, Srot, Svib and Sconf are the translocational, rotational, vibrational and
conformational entropy, respectively.

One of the main advantages of the MM/GBSA method is that the binding contributions
are calculated separately. The separation enables a more elaborated examination of terms
that improve or deteriorate the correlation with experiments. Another advantage is that
the binding free energy contribution of each individual residue can be decomposed with
little additional computational resources. The decomposition allows the identification of
binding “hot-spots” at a low cost. However, the method and its implementation are not
perfect. The following paragraphs will explain their strengths and weaknesses.
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The protein–ligand van der Waals interaction term (EvdW) generally dominates the
binding energy differences. Usually, the EvdW term has the best correlation comparing to
experimentally measured results.

Force fields sometimes tend to overestimate energy barriers, because the deformation of
proteins dislocated the conformation from local minima and yield a non-converged
energy result. As a result, the internal strength energy (ΔEint) values tend to be higher
(more positive) than the results from a quantum-mechanical method. When using single
trajectory method, the internal strength energy will be canceled, and the impact from this
problem should be minimized.

The protein–ligand electrostatic interaction term (Eelec) is essential but to some degree
problematic. The problems are mainly caused by the underestimated screening terms. The
use of a fixed protein dielectric constant of 1 and a fixed charged force field omit the
motion of proteins and may underestimate the electrostatic screening terms. Adding
Generalized Born screening terms from the solvent alleviates this problem. However, the
GB term is not always included in the scoring function and could bring extra noise.
Hence, extreme caution should be used when calculating protein-ligand interactions
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involve hydrogen bonds. The favorable scores for these interactions may result from
insufficient ΔGsolv screening term.

Eelec is not always beneficial to the correlation with experimental results. It depends on
the composition of the congeneric series being scored. Especially when only a few of the
ligands in the series can form hydrogen bonds with the protein, the correlation to
experimental data can be negatively affected.

A simple energy minimization for the complexes greatly increases computational
efficiency comparing to MD simulations. It can be completed quickly that can be fitted
into synthetic chemistry-biological test cycles. However, the protein could not be
sufficiently relaxed to accommodate numerous scaffolds in such method, and could in
theory raise a serious limitation in free energy calculation. This limitation should be
minimized when applied on a congeneris series. On the other hand, the introduction of
noise in short MD simulation trajectory sometimes produces even worse correlation to
the experimental data.

The electrostatic term Eelec for the protein is also affected by the insufficient electrostatic
screening terms. This can be more severe when salt bridges within the protein were
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disturbed by ligands at different degrees. In consequence, the Eelec term can be very noisy
for the protein binding to different ligands.

In practice, some entropy contributions for the binding process are ignored for the sake of
efficiency. Usually, the changes in translational, rotational and vibrational terms are
omitted. When scoring a congeneris series, adding such terms for ligands has little to no
effect to the ranking results, especially where the entropy contributions were estimated
using rigid rotor harmonic oscillator models. For the same series, the changes in such
entropy contributions are believed to be relatively ignorable.

In addition, the entropy term resulting from the restriction of torsional angle in the
binding process is also disregarded79. The restriction of torsional motions can possibly
result in a significant impact to rank ordering, especially in the entropic terms. However,
the calculation of torsional terms is extremely expensive and not practical under current
technology.

Although the MM/GBSA method can give decent correlation and accurate rank ordering
with experimental results, the result show larger dynamic range comparing to the
experimental range, typically 3-10 times larger. In the next section, I will build a test
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system using protein systems to examine the performance of MM/GBSA method.

2.3. Testing method and system
To validate the sampling and free energy calculation method, a series of studies were
performed before conducting the production simulation. These tests were built to
discover a good way to perform efficient simulation and obtain statistically converged
free energy results.

2.3.1 Construct initial structure
The method studies were conducted on similar systems as the systems in Chapters 3 and
4 to minimize the impact from replacing system components. We built the structure of PA
bound to 13 different mutants of TEM8, which are H57A, H57H58NN, H58A, T87S,
R88Q, K111R, L113V, D117E, Y119F, E125A, E152A, E152K, E155K, and wide type.

The structures were built in three steps. First, a structure of PA bound to TEM8 was
obtained by using the TOPMATCH80 protein structural precise alignment algorithm. A
rigid body structural alignment was applied to replace CMG2 (chain Y in PDB: 1T6B25)
using TEM8 (chain A in PDB: 3N2N29). Missing loops in PA were patched using the
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optimized conformation generated by Modeller9.1181. Second, PA domain I and III were
truncated in the simulation to improve efficiency, because these two domains are not
believed to directly contribute to the binding with TEM882. To keep the truncated PA
folded, a harmonic restraint were applied on the residues more than 14 Å away from the
binding surface in MD simulation. Different strengths of harmonic restraint were tested to
obtain minimized potential artificial impact from harmonic restraint. At last, mutations
were made on TEM8 using the mutation module in Modeller9.1181. To obtain an
optimized mutant structure, 1000 steps of energy minimization iteration were conducted
in the mutation module.

Some crystallographic water molecules are believed to be important in the protein’s
biological processes. To investigate the importance of crystallographic water molecules in
our research system, three test cases were investigated. The test cases were built based on
the structure of PA bound to wild type TEM8. The first one keeps all crystallographic
water molecules as the control group. The second one removes all crystallographic water
molecules in the structure obtained from protein data bank. The third one only keeps the
crystallographic water molecules in the binding site; in this case, the MIDAS domain in
TEM8.
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To remove energy clashes, the initial structure of PA-TEM8 complex were subjected to
an energy minimization in vacuum. The energy minimization has 10 cycles of 1,000 steps,
reducing the harmonic restraint each cycle on all protein atoms from 10 kcal·mol-1·Å-2 to
1 kcal·mol-1·Å-2 in decrements of 1 kcal·mol-1·Å-2 under the Steepest Descent method in
the CHARMM 35b6 software package83 and charmm27 force field parameters46. The
protein complex was then dissolved in a TIP384 water and 0.15 mol·L-1 NaCl box of
126Å86Å 86Å at a mixed density of 0.947 g/cm3. Extra chloride anions were used to
neutralize the positive charge of the protein complex.

2.3.2 Energy minimization
The energy minimizations of the protein solvent were conducted using NAMD 2.10-GPU
software package85 with charmm27 force field. Two cycles of 10000 steps of Conjugated
Gradient minimization were run NAMD with fixed protein atoms and without constraints,
respectively.

2.3.3 Molecular dynamics
Molecular dynamics simulations were conducted using NAMD 2.10-GPU software
package85 with charmm27 force field at constant temperature at 300 K with a damping
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coefficient of 5ps-1 coupled by Langevin dynamics86, and constant pressure at 1 bar
coupled by Langevin-Noose Hoover piston87 with a damping time of 50ps-1. Particle
Mesh Ewald88 was used to calculate long-range electrostatic interactions. The time step
was set at 2fs with the use of Rigid Bond (SHAKE) algorithm89 to restrain hydrogen
atoms with the heavy atoms they bound to.

2.3.4 Free energy calculation
The free energy calculations were conducted using CHARMM c35b6. Molecular
mechanics energies were calculated using a 999 Å cutoff distance (essentially no cutoff
for this system). Non polar solvation energy term Gnonpolar was estimated from the solvent
accessible surface area (Equation 2.4) using SASA package in CHARMM90, and
γ=0.00542kcalmol-1Å-2, β=0.92kcal/mol. The polar solvation energy GGB was
calculated with the GBSW approach91,92 implemented in CHARMM. Dielectric constants
of 4 and 80 were used for solute and solvent, respectively. CHARMM default optimized
parameters for GB-calculations93,94 were used. For each PA-TEM8 complex, the binding
free energy of MM/GBSA was estimated as follows: ΔGbind = Gcomplex – GPA – GTEM8
where ΔGbind is the binding free energy and Gcomplex, GPA, and GTEM8 are the free energies
of complex, PA, and TEM8, respectively. The binding free energy can be further
decomposed into contribution from each individual amino acid. A detailed procedure is
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shown is section 3.2.5.

2.4. Result and discussion
2.4.1 The importance of crystallographic water molecules
The crystallographic water molecules are important to maintain a stable conformation,
especially those in the binding site. In the control group, where none of the
crystallographic water molecules were removed, the structure of protein complex stayed
folded after 20ns of MD simulation with an RMSD of 1.92Å, the metal ion in MIDAS
binding site shifted 0.25Å from its initial position. In the second case, where all of the
crystallographic water molecules were removed, the structure of protein complex also
stayed folded after 20ns of MD simulation, but with a larger RMSD at 2.10Å. However,
the metal ion in MIDAS binding site shifted 2.21Å from its initial position, which
breaking the coordinate bonds in the binding site that are believed to be important to the
binding process9. In the third system, all crystallographic water molecules were removed,
except those in the binding site. As expected, the structure of protein complex stayed
folded after 20ns of MD simulation, with a larger RMSD at 1.96Å, and the metal ion in
the binding site shifted 0.23Å from its initial position. Although our result may imply that
removing those crystallographic water molecules that are not in the binding site would
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not impact the results, the deletion may still be dangerous to the accuracy of the results
and should be done with extreme caution.

Most crystallographic water molecules are not known to be involved in the binding
process. But it is sometimes non trivial to determine if a water molecule is directly or
indirectly facilitating the binding process78. In some cases, the water molecules are
required to be removed to obtain more accurate structure for the pure protein, e.g. protein
docking. When simulate proteins in non-water solvents, the decision can be even more
difficult to make95. We suggest keeping all crystallographic water molecules in the initial
structure for a long MD simulation. Thus the fluctuation on structure can be minimized,
and the chance of obtaining invalid ensemble average ad variance obtained from the MD
simulation can also be minimized.

2.4.2 Harmonics restraint on residues away from the contact surface
To optimize the method of truncation, we compared a series of harmonic restraint
parameters to maintain a stable conformation. Since PA domain I and III are known to be
less important to the binding process82, plus they are more than 20Å away from the
binding surface, they were truncated in the simulation. When no restraint is applied
(black line in Figure 2.1), the truncation destabilized the part of the protein complex that
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is close to the truncation site. To prevent unwanted unfolding on the proteins parts far
from the binding site, a harmonic restraint were applied on the residues more than 14 Å
away from the binding surface in MD simulation. The strength of harmonic restraint was
tuned between 0-10kcal mol-1Å-1 in attempt to find the best strength.

Figure 2.1 Molecular Dynamics simulation stability and equilibration. RMSF of PA residues in 200ps MD
simulation versus the shortest distance between the residue and TEM8.

Harmonic restraint of 5, or 10 kcal mol-1Å-1 yielded slightly lower RMSF results than
restraint of 1kcal mol-1Å-1on the residues far away from the binding site (Figure 2.1).
Considering the thermal noise at 300K, kBT~0.6 kcal mol-1Å-1, a harmonic restraint of 1
kcal mol-1Å-1 should be enough to limit the random drift below 1 Å. 5 or 10kcal mol-1Å-1
of harmonic restraint did not provide significant improvement comparing to the decrease
in RMSF when the strength of restraint increase from 0 to 1. Although the stronger
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restraint we tested did not interfere the dynamics of residues close to the binding side
(measured by RMSF), we picked the lowest restraint that prevented unwanted structural
changes resulting from truncation, which is 1kcal mol-1Å-1.

2.4.3 Anomalous autocorrelation times and memory kernels
To obtain independent samples for property A (Equation 2.15) from MD simulation, we
needed to examine the autocorrelation of a series of Ai. The purpose of this dissertation is
to calculate the binding free energy; thus the autocorrelation of MM/GBSA interaction
free energy between PA and wild type TEM8 is evaluated and shown in Figure 2.2.

Surprisingly, a similar trend of autocorrelation was observed for simulation of 20ns
(Figure 2.2a) and 0.2ns (Figure 2.2b). In both cases, the autocorrelation started from 0.3,
decreased to -0.3 after ~300 samples and fluctuated. Noticing that the samples in the two
cases were extracted at 5ns and 0.05ns time intervals, this autocorrelation result implies
the existence of a fractal “memory kernel” like behavior in protein dynamics. A fractal
behavior means similar or identical behavior can be observed on different scales of the
system. It is usually called a “memory kernel” in MD simulations75,96,97. In experiments,
the memory kernel is also observed in protein dynamics, but the biological function for
such phenomena is still unclear98.
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Figure 2.2 Autocorrelation of MM/GBSA interaction energy in 20ns (a) and 0.2ns (b) Protein-Protein
interaction, using window sizes of 5ns and 0.05ns, respectively. Each figure has 4000 samples that were
both collected after 40ns equilibration run.

42

(a)

(b)

Figure 2.3 Autocorrelation time of MM/GBSA interaction energy between protein A and individual residues
of protein B that has varies RMSF (a) or S2 (b) extracted from 20ns simulation using a window size of 5ns.

To further investigate the factors affect the autocorrelation time, we measured the
autocorrelation time of binding free energy contributed by individual residues on TEM8,
and compared with RMSF and an NMR property, S2. Because none of the TEM8 residues
are under any restraint and these residues are more than 14 Å from the binding site, the
dynamics of these residues are considered unaffected by the restraint applied on the
residues near the truncation site. Figure 2.3 shows that there is not an obvious correlation
between energy autocorrelation time and RMSF or S2. NMR experiments showed that the
relaxation times of the residues are also independent from RMSF or S2 96-98. Although
relaxation time is not a direct indicator of energy autocorrelation time, the dynamics
information given by relaxation time is usually correlated with the autocorrelation time of
thermodynamics properties96,99. Weak correlation between energy autocorrelation time
and dynamics properties suggests that the sampling interval of property A cannot be
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determined by measuring the dynamics properties of the system.

Figure 2.4 Autocorrelation time for MM/GBSA interaction energy in Protein-Protein interaction and
protein-ligand interactions when the ligand is on protein surface or buried, using a window size of 5ns.
Green dot lines are results from a Runs test at confidential interval of 95%. Samples have autocorrelations
between the green dot-lines can be statistically considered as independent.

Autocorrelation time in binding free energy is also related to the size and location of
ligand. We compare the MM/GBSA interaction energy autocorrelation time of PA-TEM8
complex (protein-protein), PDB: 4MRS with a buried small molecule ligand100, and PDB:
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4MQT with a small molecule ligand bind to the surface101 (Figure 2.5). The
autocorrelation protein-protein interaction energy starts higher (0.5) than that of the other
two protein-ligand interactions (0.42 and 0.29). Its autocorrelation time (the time required
to reach the green dot lines) is ~5 times longer than the other two. One possible reason is
that the protein-protein binding has larger contact surface area and involves more residues,
and more and larger memory kernels can be possibly formed, resulting in longer
autocorrelation time. Second, small molecules are not usually believed to have the
memory kernels or fractal behavior that were found in large protein molecules. The
protein-ligand interaction can be considered as a fractal object binding to a rigid object,
of which the autocorrelation is only contributed by the fractal object. But the
protein-protein interaction, theoretically, is the interaction between two fractal objects, of
which the autocorrelation is contributed by both fractal objects. The increased source of
autocorrelation leads to longer autocorrelation time and higher starting value. Third, there
is no clear evidence show that the location of the ligand affects autocorrelation time, but
it affects the starting value of the autocorrelation. The relationship between ligand
location and the autocorrelation time will need further investigation.
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Figure 2.5 Autocorrelation time of MM/GBSA interaction energy between selected residues on TEM8 and
PA, versus the radius of contact area centered to L113 residue on TEM8. Autocorrelation time is measured
by the first time the autocorrelation reached zero. A window size of 1ns is used.

The correlation between autocorrelation time and the size of the contact surface, however,
is not always positive. The auto correlation time in MM/GBSA interaction energy
becomes shorter when the radius of selected area became larger and number of selected
residue becomes larger (Figure 2.4). L113 residue locates at about the center of the
contact surface between TEM8 and PA. When the selected area becomes larger, the
interaction energies of more residues are included. The scale of fluctuation in energy will
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be changed from a smaller binding site to a larger binding site. Thus, the fractal factor is
also changed from a smaller one to a bigger one. When using certain observation
windows to calculate autocorrelation time, a change of autocorrelation time should be
expected if the fractal factor is changed. The change can be either increment or
decrement71. Although L113 was randomly selected in this case, the sharp change in
energy autocorrelation time may indicate the edge of a fractal group that share similar
dynamics property. Thus we may measure the autocorrelation time of residue groups to
determine the function group in protein complexes.

2.4.4 Langevin damping coefficient and autocorrelation
Motions in proteins can be approximately simplified to a damped harmonic oscillator
system102-104. The complex can be simplified to a two rigid balls connected by a spring
and merged in a viscous solvent. Each ball represents one protein in the complex, and the
spring mimics the interaction between the proteins (Figure 2.6). Once an excitation is
given by either the collision of Brownian motion or external excitation, the ball-spring
model starts to vibrate. When the viscosity of the solvent is very high, the damping
strength is also very high; the system needs a long time to recover the equilibration state.
When the viscosity is very low, the vibration takes a long time to decay. Both case lead to
long autocorrelation time. At some critical damping strength, the system needs the
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shortest time to fully absorb the excitation, and yields the shortest autocorrelation time. In
Langevin dynamics, the viscosity of the solvent can be modified by tuning

in Equation

2.13. Good sampling methods obtains more independent sample with given resource.
Sampling at the critical damping strength can decrease the autocorrelation time, thus
obtain more the samples per unit time.

Figure 2.6 A scheme of relationship between autocorrelation time and damping strength in a damped
harmonic oscillator system.
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Figure 2.7 MM/GBSA interaction energy of PA-TEM8(WT) complex under Langevin damping coefficient
1 ps-1 (black), 5 ps-1 (red, offset by 30 kcal/mol), 10ps-1 (blue, offset by 60 kcal/mol), 50 ps-1 (dark cyan,
offset by 90 kcal/mol),100 ps-1 (pink, offset by 120 kcal/mol), 200 ps-1 (dark yellow, offset by 150
kcal/mol). On the right, histograms show the distribution of the energy data with Gaussian fitting overlaid.

Although the motions are known to have damped harmonic oscillator like behavior, there
is no direct evidence that the energies also have similar behaviors. To investigate the
existence of these behaviors, we ran MD simulation for our protein-protein complex
using varies damping Langevin damping coefficient ranging from 1 ps-1 to 200 ps-1.
MM/GBSA interaction free energy between PA and wild type TEM8 obtained from all
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these simulations follow Gaussian distribution, which indicates that there is not
significant bias in the MD sampling processes (Figure 2.6). When damping coefficient 10
ps-1 and 50 ps-1 were used, the autocorrelation in MM/GBSA interaction energy decays
significantly faster than those using other damping coefficients. The autocorrelation times
are also ~10 times shorter than the other cases. Energies calculated using damping
coefficient 1 ps-1, 5 ps-1, 100 ps-1, and 200 ps-1 have similar autocorrelation time. If we
compare the results with the theory shown in Figure 2.6, the critical damping coefficient
should be some value between 10 ps-1 and 50 ps-1.

Figure 2.8 Autocorrelation of MM/GBSA interaction free energy PA-TEM8(WT) complex exacted from 15
ns MD simulations under different Langevin damping coefficient γ. Green dot lines are results from a Runs
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test at confidential interval of 95%.

Samples have autocorrelation within the green dot lines is

calculated can be statistically considered as independent.

Figure 2.9 Average RMSF of all Cα atoms on TEM8 during 20ns MD simulation of PA-TEM8 complex
using Langevin Damping coefficient from 1 ps-1 to 200 ps-1.

Changing Langevin damping coefficients also brings side effects. Damping coefficients
of 1 ps-1 to 5 ps-1 are commonly used to recover the dynamics of water molecules86,105.
The change in viscosity in solvent have been shown to inhibit the local dynamics of
protein, and enhanced the sampling of local conformation106. However, in our simulation,
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the damping coefficients were modified for both protein and solvent. We found the
increased Langevin Damping coefficient lowered the RMSF of residues in MD
simulation, which may limit the conformation space visited in given simulation time, thus
decrease the sampling efficiency.

In all, the MM/GBSA interaction free energy in protein-protein complex has similar
behaviors as damped harmonic oscillator. A critical damping coefficient that can yield the
shortest autocorrelation time exists. However, the side effected comes with the
advantages hasn’t been compared with experimental data yet. The use of damping
Langevin damping coefficient needs to be further investigated. Considering the benefits
and risks, the simulations in the following chapters were conducted using 5ps-1 Langevin
damping coefficient.
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2.4.5 Equilibration and production time

Figure 2.10. Solvation energy (van der Waals and Coulombic interaction energy between proteins and
solvent) in 20ns MD simulation. The green dot line is marked at 5ns as visual aid.

The initial part of a Molecular Dynamics trajectory is usually considered as equilibration
phase, and not used for further analysis40,107,108. There exists numerous of methods to set
the length of equilibration phase, such as by measuring the RMSD41, total energy109, or
imperial110,111, etc . Because solvation energy is one major component of MM/GBSA
binding free energy, this dissertation uses the interaction energy between the protein
complex and water as an indicator of “equilibration”, at which the layers of solvent
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shells84 have been formed. Figure 2.10 shows that the solvation energy of the PA-TEM8
complex decreased in the first 5ns and then fluctuated around -5500kcal/mol from 5ns to
20ns. Thus, simulation after 5ns is assumed to be “equilibrated”.

If we consider the assignment of initial velocity as an external excitation to the protein
complex, the oscillators started to vibrate following the external energy source. It is
similar to observations in protein far infrared excitation experiments112,113, where the
vibration resulted from excitation lasted more than 30 periods. To reveal the vibration
modes of the protein complex, the influence from artificial excitation needs to be
minimized. The memory-kernel-like behaviors are usually more prevalent in large
biomolecules rather than small inorganic molecules. Thus, a longer equilibration phase
may be required for protein-protein complexes than for small molecules or
protein-small-molecule complexes.

To test our hypodissertation, we ran 10 repeats of MD simulations to measure the
standard deviation in energies calculated from these 10 repeats using different
equilibration lengths and production length. Longer equilibration times and longer
production times indeed yielded smaller standard deviations in the results, indicating
higher precision. Unlike the commonly used 10-100ps equilibration time in protein-small
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molecule binding40,107,114, equilibration times shorter than 1ns in this protein-protein
binding may still give low precision even the production time is longer than 8 n. If we
consider running simulations at a predetermined computing resource, the equilibration
time and production time add up to a given length. Imagine there exists a line x + y = t in
Figure 2.11, where x is equilibration time, y is production time, and t is the given
simulation length. When simulation time is longer than 10ns (x + y > 10), the simulation
precision will benefit from the extension of production time, especially when more than
5ns equilibration time is used.
For these experiments, we chose to use 5ns equilibration time out of the 20ns MD
simulation to obtain MM/GBSA interaction free energy at the best possible precision.
Only the other 15ns simulation was used for free energy calculation.
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Figure 2.11 Standard deviation of the average interaction energy between two proteins extracted from 10
repeats of 20ns simulation vs length of equilibration time and production time.

2.4.6 The accuracy of MM/GBSA
After all simulation parameters were selected, we calculated the MM/GBSA interaction
free energy between PA and 13 TEM8 mutants from 10 repeats of 20ns MD simulation,
and compared the results with experimentally measured binding affinity. The
experimental data were dissociation constants collected by our collaborators using
Surface Plasmon Resonance experiments. The calculated binding free energy has a
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correlation of 0.57 with experimental values. With 10 repeats of independent simulation,
the standard error in calculated free energy is ~1kcal/mol. 20ns simulation yielded
satisfactory results in estimating the binding free energy of protein-protein interactions.
However, the absolute calculated energies are ~10 times exaggerated compared to the
experimental values, suggesting that large conformation changse and unfolding caused by
mutations may not be recovered in the simulation.

Figure 2.12. Comparison of calculated MM/GBSA interaction free energy and experimental binding affinity.
Error bars show the standard error of values.
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2.5 Conclusion
Protein-protein interactions exhibit memory-kernel-like fractal behavior, which causes
anomalous autocorrelation times. To obtain statistically meaningful value of simulation
properties, independent samples need to be obtained from simulation. The slowly
decaying autocorrelation in protein-protein interaction makes the sampling process very
challenging. A carefully tuned Langevin damp coefficient can serve as the critical
damping strength in damped harmonic oscillator model, yielding minimal autocorrelation
time. The tuning of damping coefficient may come with unwanted side effects, and
requires further investigation.

Crystallographic water molecules in the binding site are necessary to model the binding
interactions. Failure to correctly locate the crystallographic water molecules may lead to
artificial conformational change or unfolding that lead to simulation errors.

Compared to the simulation of protein and small ligand binding, longer equilibration
phases are necessary before the production MD simulation of protein-protein interactions,
e.g. at least 1ns. Independent MD simulation using different initial velocities are chosen
to be the sampling method. For PA-TEM8 and similar protein-protein complexes, we
used 10 repeats of a 20ns simulation, including 5ns as the equilibration phase, and
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obtained a correlation of 0.57 with experimental binding affinity. Similar sampling
methods were used in the following chapters to estimate the MM/GBSA binding free
energy.
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CHAPTER 3

EFFECT FROM METAL ION IN TUMOR ENDOTHELIAL MARKER 8 AND
ANTHRAX PROTECTIVE ANTIGEN

ABSTRACT

Anthrax toxin, the causative agent of anthrax, infects the host cells after the protective
antigen binds to a cellular receptor. One of the receptors, tumor endothelial marker 8
(TEM8), is reported to be a potential anticancer target due to its over-expression during
tumor angiogenesis. To extend our surface plasmon resonance (SPR) study in PA/TEM8
binding, we present a systematic computational approach to reveal the role of an integral
metal ion on receptor structure and binding thermodynamics. We estimated the
interaction energy between PA and TEM8 using computer simulation methods. In
addition, the calculated relative dissociation constant between TEM8 and PA in the
presence of different divalent metal ions was verified via SPR and compared with
previous publications. Consistent with our experimental study, computational results
indicate the metal ion in TEM8 contributes significantly to the binding affinity, and
TEM8/PA binding is more favorable in the presence of Mg2+ than Ca2+. In addition, some
of the residues coordinated to the metal ion partially compensate the loss in interaction
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energy resulting from metal ion replacement. Further, computational analyses suggest
that the differences in TEM8/PA binding affinity are comparable to behaviors observed in
closely related integrin proteins, which are known to adopt two conformations linked to
changes in activity. Specifically, we found TEM8 remains in a conformation analogous to
an integrin open (high-affinity) conformation when Mg2+ is bound to the TEM8 metal
ion-dependent adhesion site (MIDAS). Nonetheless, molecular dynamics simulations
suggest that when Ca2+ occupies the MIDAS, TEM8 may favor a locally unfolded
conformation analogous to integrin αL.
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3.1 Introduction
Since the bioterrorism attack in 2001, the need to understand and develop
countermeasures for anthrax infection has demanded greater attention7. The infection is
typically transmitted through ingestion, inhalation or cutaneous, followed by cellular
infection at the site of contact, causing distinct clinical symptoms115. The mechanism of
cellular anthrax infection begins when protective antigen (PA), a component of anthrax
toxin, binds to anthrax receptors on the cell surface17.

Tumor endothelial marker 8 (TEM8) is one of the anthrax cell surface receptors in the
human body17. Anthrax protective antigen can transport anthrax lethal factor and edema
factor into human cells once it forms a pore after binding to its receptors9. TEM8 is also
known to be over expressed in tumor cells17, and was originally identified as the product
of gene upregulation in tumor endothelium116. Since TEM8 functions in angiogenic
processes that are required for tumor growth117,118, the receptor has generated much
interest as either a cancer marker119,120 or a target for tumor-specific therapies120.
Anti-TEM8 antibodies were developed by modifying PA to inhibit function of
TEM8121,122.

X-ray crystallographic studies9 demonstrated that TEM8 is a von Willebrand factor type
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A protein that contains a divalent cation in a metal ion dependent adhesion site (i.e. the
MIDAS domain). Most other von Willebrand factor A proteins, including integrins, bind
their relevant physiological ligand(s) via the metal cation. TEM8 mutants that disrupt
metal binding, or wild-type TEM8 that lacks the divalent metal, yield a significant
decrease in TEM8-PA binding affinity29. PA is believed to occupy the same binding site
as

physiological

extracellular membrane

ligand(s)123. Consequently,

TEM8-PA

interactions can be used as a model for studying TEM8 binding behavior both to its
physiological ligand and anthrax protective antigen, to modulate the angiogenic effect(s)
of TEM8 and the anthrax infection pathway. However, the exact structure of TEM8-PA
complex and the molecular mechanism by which TEM8 exerts its angiogenic effect
remain unclear.

Another anthrax receptor, capillary morphogenesis gene 2 (CMG2), shares 40% amino
acid identity with TEM8, with close to 60% identity in the PA binding domain. The
affinity between another anthrax receptor CMG2 and PA is significantly affected by the
choice of metal cation24. Three possible metal ions facilitate the binding by coordinating
to the MIDAS in CMG2: Mg2+ has the strongest binding affinity, followed by Zn2+, and
then Ca2+. Similar results were found for TEM8124. However, a systematic examination of
the role of the divalent cation on the TEM8-PA interaction has not been carried out.
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In addition, several groups have taken advantage of the structural similarity between
integrin α and TEM8 MIDAS domains. They speculate that the binding of TEM8
cytosolic domains to actin can result in conformational changes that switch the TEM8
MIDAS domain from high to low affinity states, and that these two conformational states
could resemble the “open” and “closed” conformations of integrin MIDAS domains,
respectively125,126. Presumably, such conformational changes could be responsible for
TEM8 signaling. TEM8 X-ray structures show greater similarity to the integrin α I
domain “open” conformation than to the “closed” conformation. Many integrin α I
domain crystal structures are always bound to a ligand in “open” conformation, and not
bound to a ligand in “closed” conformation. Although the TEM8 crystal structure doesn’t
contain a ligand, it is believed to be an “open” conformation. The integrin α conformation
change is believed to be strongly coupled to the conformation of a phenylalanine on the
C-terminal and a tyrosine near the MIDAS domain127. F205 and T118 are the
corresponding residues conserved in TEM8, comparing to the phenylalanine and tyrosine
in integrin α. Mutation of the TEM8 phenylalanine 205, highly conserved among related
integrins, to tryptophan (F205W) has been shown to lock TEM8 into a high affinity state.
Conversely, the T118A mutation lowers the binding affinity to PA by ~103 fold128.
However, no structural data directly supporting different conformational states has been
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generated for TEM8.

To investigate the role of the metal ion in the TEM8 and PA interaction, we generated a
TEM8-PA complex structure model based on the highly homologous CMG2-PA crystal
structure and evaluated the molecular model in the presence of different divalent cations.
We also used our model to examine the possibility of “open” to “closed” conformational
changes previously suggested for TEM8125,128. To validate the computational model, our
experimental collaborators measured binding affinity through surface plasmon resonance
(SPR) experiments that focused on the PA-TEM8 interaction in the presence of Mg2+ and
Ca2+. We found the molecular reason for the difference binding affinity between PA and
TEM8, the “hot-spot” residues contribute most binding free, and examined the possibility
of TEM8 “open” and “closed” conformation change.

3.2 Method
3.2.1 Preparation of Complex
To model TEM8-PA complex, we started from the crystal structure of CMG2-PA complex
(1T6B25) and the crystal structure of TEM8 (3N2N29), a structure of PA binding TEM8
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was obtained by using the TOPMATCH80 protein structural precise alignment algorithm.
A rigid body structural alignment was applied to replace CMG2 in 1T6B using TEM8
from 3N2N chain A at RMSD=0.66 Å. Missing loops in PA far (more than 14Å) from the
binding surface were patched using the optimized conformation generated by
Modeller9.1181.

To reduce the computing cost, PA domain I and III were truncated in the simulation to
improve efficiency. We consider the truncation will not significantly affect the binding
interaction energy, because the truncated domains are more than 20Å away from the
binding surface and are not known to contribute binding interaction energy82. To keep the
truncated PA folded, a harmonic restraint were applied on the residues more than 14 Å
away from the binding surface in MD simulation. A harmonic restraint of 1 kcal·mol -1
was chosen based on our tests of multiple restraint strengths as shown in section 2.4.1, to
minimized the potential artificial impact from harmonic restraint. The harmonic restraint
didn’t significantly affect the dynamics properties of the protein complex. Hence, we
assume the interaction energy was not significantly affected either. Mg2+ ion was used in
the original crystal structure of TEM8. To study the effects of different metal ions, we
replaced the Mg2+ Ca2+, and set their initial coordinates as the same as Mg2+.
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To model free TEM8, the crystal structure of the TEM8 monomer chain “A” was also
used. Ion replacement, energy minimization and molecular dynamics were done in the
same way as for TEM8-PA complex, but without restraints.

3.2.2 Molecular Dynamics simulation
To minimize the possible errors resulting from homology modeling, we carefully
designed the modeling process. An RMSD of 0.14Å (comparing to initial structure, and
not including missing loops) on all heavy atoms was achieved after all energy
minimization (before MD simulation in NAMD), which can yield satisfactory accuracy in
binding affinity calculation129.

Before dissolving the protein in explicit solvent, the initial atomic coordinates of
PA-TEM8 complexes were first subjected to an energy minimization in vacuum to
remove energy clashes. The energy minimization has 10 cycles of 1,000 steps, reducing
the harmonic restraint each cycle on all protein atoms from 10 kcal·mol-1·Å-2 to 1
kcal·mol-1·Å-2 in decrements of 1 kcal·mol-1·Å-2 under Steepest Descent method in
CHARMM 35b6 software package83 and charmm27 force field parameters46. The protein
was then dissolved in a TIP384 water and 0.15mol·L-1 NaCl box of 126Å86Å 86Å at a
mixed density of 0.947g/cm3. Extra chloride anions were used to neutralize the positive
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charge of the protein complex.

After the protein solvent was generated, further energy minimization and molecular
dynamics simulations of protein solution were run using the NAMD 2.10-GPU software
package85 with charmm27 force field parameters. Two cycles of 10000 steps of
Conjugated Gradient minimization were run NAMD with fixed protein atoms and
without constraints, respectively. Finally, 10 repeats of 20 ns molecular dynamics using
different random seeds for starting velocities were produced114. Temperature was set at
300 K with a damping coefficient of 5ps-1 using Langevin dynamics86. Pressure was set at
1 bar using a Langevin-Noose Hoover piston87 with a damping time of 50ps-1. Particle
Mesh Ewald88 was used to calculate long-range electrostatic interactions. The time step
was set at 2fs with the use of Rigid Bond algorithm89 between hydrogen atoms and heavy
atoms.

The PA-TEM8 system has ~90000 atoms, the TEM8 system has ~60000 atoms, and the
total simulation time is 800 ns. The MD simulations were run on 16 cores Intel Xeon
E5-2665 and 2 NVIDIA K20 GPU.
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3.2.3 Simulation Stability

Figure 3.1 Molecular Dynamics simulation stability and equilibration. Black line shows RMSD of
PA-TEM8 complex in 20ns MD simulation. Red line shows van de Waals and Columbic interaction energy
between the protein complex and surrounding water molecules.

An optimized harmonic restraint parameter of 1kcal·mol-1·Å-2 was applied on PA residues
that are more than 14 Å from any atom in TEM8 (Section 2.4.1). Comparing to the
superposed crystal structure, the RMSD of the TEM8-PA complex simulation fluctuated
around 2.3 Å after the first 5ns of simulation (black line in Figure 3.1b).

3.2.4 MM/GBSA energy calculation
MM/GBSA is an end point energy calculation method that has been widely used to
estimate the relative binding interaction energy35,40,107,130. In addition to the molecular
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mechanics energies, the polar and non-polar solvation free energies are simplified with
generalized Born implicit solvent approximation and solvent-accessible surface area term,
respectively131. In this study, because the only difference in the two protein compounds is
the metal ion, we assume the difference in translational and rotational entropies upon
binding can be omitted. Thus, the binding interaction energies can be estimated according
to the equation ΔGbind = ΔEMM + ΔGGB + ΔGnonpolar – TΔS, where ΔEMM is the difference
of gas-phase interaction energy between proteins, including the Columbic, van der Waals,
bond, angle and dihedral energies; ΔGGB and ΔGnonpolar are the polar and nonpolar
components of the desolvation free energy, respectively; -TΔS is the change in
conformational entropy during the binding process.

The change in configurational entropy upon binding was calculated using the
Quasi-Harmonic estimation. The variance in entropic contribution (-TΔS) of PA-TEM8 in
the presence of different metal ion is relatively small (0.03kcal/mol) compared to the
variance in MM/GBSA energies (2.23 kcal/mol). The Quasi-Harmonic entropy did not
converge in 20ns simulation trajectory for a large protein compound. Moreover, the
difference is much smaller than the precision of the interaction energy calculation.
Therefore, to save computing time and exclude the possible errors in not converged
Quasi-Harmonic entropy calculation, we assume that the volumes of configuration space
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occupied by the ligand and protein change negligibly upon association, and the –TΔS
term was not included in binding free energy calculation.

MM/GBSA free energies were calculated from snapshots taken from MD trajectory at
commonly used40 5 ps intervals from 20 ns MD simulation. The first 5 ns simulation was
considered as pre-equilibrium stage based on the interaction between the protein complex
and water (red line in Figure 3.1b), thus any data from the first 5ns simulation were not
used in further analysis. The single trajectory interaction energy calculation technique
was used to cancel the errors resulted from internal strength energy, thermal noise and
potentially inadequate configuration sampling when the energies were calculated from
multiple simulations43. The conformation ensemble of the PA, TEM8 and PA-TEM8
complex were obtained from the same MD trajectory.

For each PA-TEM8 complex, the binding free energy of MM/GBSA was estimated as
follows: ΔGbind = Gcomplex – GPA – GTEM8 where ΔGbind is the binding free energy and
Gcomplex, GPA, and GTEM8 are the free energies of complex, PA, and TEM8, respectively.
When calculating the MM/GBSA interaction energy between PA and TEM8, the
unwanted protein and solvent molecules were removed, e.g. PA and solvent molecules
were removed when calculating GTEM8. When calculating interaction energy contributed
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by individual residue, all solvent molecules were also removed; but for the unwanted
protein, only the charges were removed, the structure was kept to maintain the proper
Born radii for the residues. Graphs and visual inspections were made using VMD132.

The free energies of each system were calculated using an MM/GBSA method
implemented in CHARMM. EMM was determined by CHARMM with 999Å cutoff
distance (essentially no cutoff), and Gnonpolar =γA+b was estimated from the solvent
accessible surface area (A in the equation) using SASA package in CHARMM90, and
γ=0.00542kcalmol-1Å-2, β=0.92kcal/mol. GGB was calculated with the GBSW
approach91,92 implemented in CHARMM. Dielectric constants of 4 and 80 were used for
solute and solvent, respectively. CHARMM default optimized parameters for
GB-calculations93,94 were used. For each PA-TEM8 complex, the binding free energy of
MM/GBSA was estimated as follows: ΔGbind = Gcomplex – GPA – GTEM8 where ΔGbind is the
binding free energy and Gcomplex, GPA, and GTEM8 are the free energies of complex, PA,
and TEM8, respectively.

3.2.5 Energy Decomposition
Biding free energies resulting from non-bond interactions were decomposed at atomic
level to evaluate the contribution of individual residues to the binding free energy. Van
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der Waals and Columbic interaction energies were calculated using a traditional
Molecular Mechanics method (INTE in CHARMM). For residue i in TEM8, j in PA, the
MM interaction energy contribution of atom i between the two proteins was calculated by

The polar solvation energy was calculated using generalized Born (GBSW in CHARMM)
approach. For residue i in TEM8, and PA, the polar solvation free energy contribution of
atom i between the two proteins was calculated by

The non-polar solvation energy was calculated using solvent accessible surface area
(SASA in charm) approach. For residue i in TEM8, and PA, the non-polar solvation free
energy contribution of atom i between the two proteins was calculated by

The summation of energies calculating from equation (3.1-3.3) gives the free energy
contribution of residue i.

3.3 Results
3.3.1 Mg2+ results in higher TEM8/PA binding affinity than Ca2+
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MM/GBSA Interaction Energy
Metal ion
in PA/TEM8

Δ Eele

ΔEvdw

ΔGSA

ΔGGB

ΔEvdw +ΔGSA ΔEele+ΔGGB

ΔGcal.

ΔGexp

Mg2+

-28.65±3.78 -68.75±0.63 -13.49±0.10 7.13±3.01 -82.24±0.71 -21.52±0.45 -103.76±0.94 -12.82±0.10

2+

-22.75±4.12 -72.58±1.24 -13.48±0.14 7.28±3.54 -86.06±1.24 -15.47±0.85 -101.53±0.87 -10.01±0.10

Ca

Table 3.1 Experimental and calculated interaction energies (kcal/mol) for PA-TEM8 binding system. The
standard error was estimated over the mean of 10 repeats, each repeat has 3000 data points. E ele is the
Columbic energy, Evdw is the van der Waals energy, GSA is the non-polar solvation free energy, GGB is the
polar solvation free energy, Gcal is the calculated free energy, Gexp is the experimental free energy.

To measure the binding interaction energy between TEM8 and PA in the presence of
different metal ions, the dissociation constant was measured experimentally by SPR in
the presence of Mg2+ and Ca2+. Corresponding cations were placed in MIDAS domain in
simulation models. As shown in Table 3.1, experiments showed TEM8 bound to PA in the
presence of Mg2+ 2.81kcal·mol-1 stronger than in the presence of Ca2+. Simulation data
shows a difference of 2.23 kcal·mol-1.

Stronger electrostatic interaction (ΔEele+ΔGGB) was observed in the presence of Mg2+
comparing to Ca2+. Weaker van der Waals interactions were observed in the presence of
Mg2+. The major difference comes from the Coulombic interaction. On the contrary, the
GB energies do not show much difference. The GB energy mimics the solvation
screening effect to partially cancel out about 25% of the Coulombic term. Surprisingly,
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the summation of Coulombic term and GB term only has less than 1kcal/mol in standard
error, which is, more than 60% less than the errors in either ΔEele or ΔGGB. We ascribe it
to the exaggerated error in Coulombic energy calculated in vacuum, which results from
the lack of screening terms for the interaction between exposed charged residues. Adding
in GB terms largely cancels the exaggerated Coulombic energy between these exposed
residues.

The fluctuation (standard deviation) in vdW energy is comparable to the electrostatic
term, but much smaller than the Coulombic term. It indicates the fluctuation in short
range non-bond energy is much less than the long range electrostatic energies. And the
short range energy term is less affected by the lack of solvation free energy, which can be
further supported by the small variance and error in the non-polar solvation energy term
GSA.

In SPR experiments, TEM8 shows more than 150 times higher binding affinity towards
PA in 1mmol Mg2+ than in 1mmol Ca2+ solution. The trend and magnitude are consistent
with our theoretical results. When replacing the metal ion from Mg2+ to Ca2+, the on rate
is about 5 fold lower, however, the dissociation rate becomes 100 times faster. kon and
kdiss in the Mg2+ and Ca2+ mixture are similar to the results from the Mg2+ solution. First,
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it suggests the TEM8 is less active towards PA in the aqueous solution containing Ca2+.
Secondly, even if it binds to PA in Ca2+ solution, the complex it still less stable than in the
presence of Mg2+. Above all, while the Mg2+ ion stabilizes the protein complex mainly by
decelerating the dissociation, it also slightly accelerates the binding process.

Experimental Binding Affinities between PA and TEM8
Metal ion
in PA/TEM8

Kd (nM)

kon(104/(MŸ
sec))

kdiss(10-5/sec)

Mg2+

3.33±1.12

1.57±0.19

5.17±1.65

Ca2+
Mg2+&Ca2+

571±170
3.98±0.20

8.67±1.86
1.07±0.13

487±146
4.22±0.35

Table 3.2 SPR Experimental data of PA-TEM8 binding in the present of Mg2+ and Ca2+ ion. Data
contributed by experimental collaborator.
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3.3.2 Mg2+ interacts stronger to the surroundings than Ca2+

Figure 3.2A Diagram of MIDAS coordination structure in TEM8-PA complex. M is the metal ion on
MIDAS domain. THR118, SER52 and SER54 are residues on TEM8. ASP683 is a residue on PA. The
metal ion and oxygen atoms involve the coordinating are in bigger size. The other atoms are in smaller size.

Figure 3.2B Distance between metal ion and the six coordination oxygen atoms in MIDAS. The residue
names are the same as shown in Figure 3.2a. Error bars show standard error of the mean from 10 individual
20ns MD simulations.
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Figure 3.2C MM/GBSA interaction energy between metal ion and residues on PA/TEM8 complex.
Residues are on TEM8 if not marked on PA. WaterA and WaterB are the same molecules shown in Figure
3.2a.

The distances between Mg2+ and all the coordinating oxygen atoms are shorter than those
between Ca2+ and the oxygen atoms (Figure 3.2B). This results in Mg2+ interacting more
strongly with the residues and water molecules around it (within 4.0 Å) relative to Ca2+
(Fig 2C). Among the three surrounding residues and the three water molecules directly
interacts with the metal ion in MIDAS (as shown in Figure 3.2A), PA-ASP683 and
TEM8-SER52/54 have larger RMSF in the presence of Ca2+ than Mg2+ (Table S3.1). The
results can be interpreted as Ca2+ expands the size of MIDAS domain and leads to weaker
interactions with residues.
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Metal ion, Domain
Mg 2+
PA
TEM8
Water
Total
Ca 2+
PA
TEM8
Water
Total

<ΔEvdw >

<ΔEelec>

<ΔGGB>

<ΔEelec+ΔGGB>

<ΔGbind >

9.56±0.14
7.20±0.09
12.16±0.06
28.92±0.10

-111.08±0.28
-173.43±1.52
-36.66±0.04
-321.17±0.89

71.72±0.25
119.39±1.44
-1.52±0.08
189.59±0.85

-27.09±0.08
-54.03±0.36
-33.21±0.08
-114.33±0.22

-29.80±0.14
-46.83±0.29
-26.03±0.11
-102.67±0.20

9.16±0.18
-106.58±0.97
73.74±0.97
-20.16±0.90
12.36±0.34
-164.35±1.43
118.41±1.36
-25.78±0.98
11.53±0.63
-26.29±1.06
0.47±0.23
-22.80±1.24
33.05±0.43
-297.22±1.17
192.62±0.98
-68.74±1.05
Note: Energies are the mean of 10 repeats ± standard error , in kcal/mol .

-23.67±0.84
-33.58±0.86
-14.30±0.73
-71.55±0.81

Table 3.3 van der Waals, Columbic and generalized Born interaction energy between PA, TEM8, coordinate
water and metal ions.

Mg2+ interacts more strongly to PA, TEM8 and the coordinated water molecules than
Ca2+ in terms of both vdW and electrostatic energy (Table 3.3). As the distances between
the metal ion and the surrounding residues increase, all interaction energies between the
metal ion and PA/TEM8/Water are weakened. This is one possible reason for the lower
binding affinity in Ca2+ solution we observed in experiment.

The interaction energy with PA contributed by individual residues on TEM8 are also
affected by the replacement of metal ion. Figure 3.3 shows the changes on the
non-MIDAS residues (LYS111, ASP117, TYR119) are from the errors in calculation. The
residues on MIDAS domain interact more weakly to PA when Mg2+ is in position,
compared to Ca2+. This is opposite to the results of interaction energy between the
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residues and metal ions. When Ca2+ is in position, the expanded MIDAS coordination and
weakened local interaction (Figure 3.2) makes the residues on TEM8 MIDAS domain
interact stronger to PA in compensate.

Figure 3.3 Biggest changes in interaction energy with PA (summation of vdW, Columbic and Generalized
Born energies) contributed by individual residues on TEM8 resulting from metal ion replacement.

3.3.3 Metal ion in unbound TEM8
To explore further the reason for the different binding affinity contributed from metal ion,
we simulated the unbound TEM8 containing Mg2+, Ca2+ or no metal ion in its MIDAS
domain. Each simulation was 20ns long. The crystal structure 3N2N chain A has Mg2+ as
the MIDAS metal ion, and its MIDAS domain retained the original conformation by
holding an RMSD of 0.28Å after 20ns(Table 3.4). As a substitute ion, Ca2+ does not fit
into the MIDAS binding site as well as Mg2+ because of its larger ion radius. Whereas, it
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expanded the MIDAS domain more severely than the distinction in ion size, so much so
that the coordination residues cannot hold their original conformation and started to
unfold. If no metal ion was present, the MIDAS domain unfolded faster than in the
presence of Ca2+. This agrees with the results of integrin αL crystal structure in different
metal ion conditions133.

Metal ion
in PA/TEM8

Mg2+
2+

Ca
None

RMSD of MIDAS Residues
RMSD (Å)
0.1ns
0.5ns
5ns
20ns
0.27±0.03 0.29±0.04 0.29±0.04 0.28±0.04
0.67±0.22 1.07±0.24 1.25±0.29 1.23±0.26
0.82±0.32 1.32±0.25 2.24±0.22 2.65±0.27

All data are mean of 10 repeats of 20ns simulation ±SE.
Table 3.4. RMSD of residues (SER52, SER54, THR118) coordinate to the metal ion in 20 ns simulation,
comparing to crystal structure 3N2N chain A.

Unfold was observed in all of the 10 repeats of 20ns simulation for TEM8 includes either
Ca2+ or no metal ion in MIDAS domain. This could be a result of unstable conformation
generated by homology modeling method. Comparing to the structural study of integrin
αL, it may imply that TEM8 possesses a slightly different conformation when Ca2+ is
present and another obviously different conformation when there is no metal ion in
MIDAS domain.
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3.3.4 PA-TEM8 interaction mechanism

Figure 3.4 MM/GBSA interaction energy contributed by individual residues on TEM8 (A) and PA(B), in
kcal/mol. Residues are colored by the strength of interaction energy.

TEM8 binds to PA via a buried surface area of more than 2200 Å2 (Figure 3.4A). Among
all the residues in the two proteins, residues on the contact surface contribute most of the
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interaction energy. Among the contact surface on TEM8, α2-α3 loop and β2-β3 loop
contribute more interaction energy than the other area. From β2-β3 loop to β5-β6 loop,
the interaction energy donated by individual residues becomes less and less. Residues
near the metal ion, D50, S52, T118 and D150, show repulsive interaction to PA. As
expected, residues near the contact surface contribute more interaction energy than the
further ones.

PA interacts with TEM8 mainly through its domain 4. PA domain 2 barely shows any
interaction to TEM8, except a few residues adjacent to domain 4. The loop contains D683
and the two beta strands interact with TEM8 most strongly. D683 is the only residue on
PA that involves in the formation of MIDAS. It exhibits the strongest interaction with
TEM8 among all the residues on PA. Strong Columbic interaction combined with
favorable cross polarization energy (electrostatic screening term)134 composite the
extremely attractive interaction between D683 and TEM8. The favorable electrostatic
screening term indicates the stronger cross polarization effect between D683 and TEM8
in the bound complex than in the separated proteins, which accelerates the binding
process.

Slightly repulsive vdW interaction was discovered between D683 and TEM8,

to partially compensate the extremely strong electrostatic interaction.
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Figure 3.5 PA-TEM8 contact surface model and details of their interaction. (A) A model of PA-TEM8
contact surface (PA, gray; TEM8, red; Mg2+, purple). (B) The hydrogen bonds formed between PA and
TEM8. Hydrogen bonds are shown in dash lines. (C) Y119 residue on TEM8 inserts to the gap between PA
domain 2 and domain 4. (D) Y160 residue on TEM8 inserts to the pocket on the side wall of PA domain 2.
(E) L113 residue on TEM8 inserts to the hydrophobic pocket on PA domain 4. And there is a large contact
surface between TEM8 residue 115 to 117 and N682 and I656 on PA. Yellow clouds in (C,D,E) are the
pockets in PA. The pockets are made using a surface probe for PA atoms within 4.0Å of the inserting
residue on TEM8.
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In addition to D683, the salt bridges and hydrophobic insertion on large contact area
between PA and TEM8 are also responsible for the strong binding. 4 salt bridges (Figure
3.5B), 3 hydrophobic pocket insertion (Figure 3.5CDE) and the buried surface area near
MIDAS domain (Figure 3.5E) constitute the majority of PA-TEM8 interaction.
TEM8-K111&PA-E650 (Figure 3.5B) salt bridge and TEM8-L113 insertion (Figure 3.5E)
contribute the majority of interaction energy on theα2-α3 loop (based on Figure 3.3A) of
contact surface. On the left side, salt bridges formed by TEM8-E122/E125&PA-R344 and
the hydrophobic pocket formed by TEM8-Y160&PA-G342/A341 locked the binding
surface. TEM8-K51&PA-E654 and TEM8-R88&PA-D658 form salt bridges near the
MIDAS metal ion to secure the shape of MIDAS pocket. TEM8-Y119 inserts into a big
hydrophobic pocked in PA formed by PA-E342/R659/M662/Y681. Y119 is directly
connected to T118, its insertion also stabilized T118 in its high affinity conformation.
Comparing to the residues on the inner contact surface, the residues on the edges of the
contact surface have larger standard errors in interaction energies. This is understandable
because the less buried residues are usually more flexible and, hence, suffer more
energetic and conformational fluctuation originated from the solvent.
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3.3.5 Ratchet like Hydrophobic Lock

Figure 3.6 Comparison of the key phenylalanine on integrins and TEM8 controlling conformation change.
Proteins in red and cyan are integrin M in closed and open conformations, respectively. Protein in yellow is
TEM8. The key phenylalanine residues (F302 on integrin M and F205 on TEM8) are highlighted. The
clouds show the residues within 4.0Å of the key phenylalanine made using 1.4Å surface probe. (A)
Comparing integrin M close and open conformation with TEM8. (B) F205 on TEM8 and the residues
within 4.0 Å.

A hydrophobic lock regulates the conformation change in integrin α proteins, which are
40% structurally similar to TEM8. In integrin αM, F302 is well inserted in the
hydrophobic lock when it is in the closed conformation, and it becomes exposed in open
conformation (Orange and cyan parts in Figure 3.6A). The conversion from closed to
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open conformation comes with more than 10Å displacement on F302 in the integrin αM.
In TEM8, F205 plays a similar role as F302 in integrinαM. Based on the location of F205,
TEM8 is in an open conformation (Yellow residue in Figure 3.6A). Different to integrins,
although TEM8 is considered in an open conformation, F205 in TEM8 is more buried
than F302 in integrin open conformation.

TEM8
α M open

SASA (Å)
28.33±0.16
161.95±0.27

E F205
9.63±0.07
20.75±0.07

α M close

13.68±0.07

8.23±0.07

α L open

53.28±0.25

18.55±0.07

α L close

3.99±0.08

9.85±0.07

All data are the mean of 3000 frames exact from
15ns simulation ± SE. Energies are in kcal/mol.
Table 3.5 Solvent accessible surface area (SASA) of TEM8 F205, integrin αL F292, integrin αM F302, and
their interaction energy (vdW, Columbic and Generalized Born energies) between the rest part of the
protein.

In TEM8, F205 is more exposed than in close conformation by possessing larger solvent
accessible surface area, but not as exposed as the phenylalanine in integrin open
conformation (Table 3.5). Comparing to TEM8, in integrins, the phenylalanine (F292 in
integrin αL and F302 in integrin αM) has 10 times larger solvent accessible surface area in
open conformation than in closed conformation. It also suffers a penalty in energy of
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9~12 kcal/mol (Table 3.5) when integrins shifted conformation from closed to open. The
energy terms of TEM8 F205 appears to be on the same magnitude as phenylalanine in
integrin closed conformation. Referring to the integrins, we suggest that TEM8 is in an
open conformation, but it does not suffer the energy penalty as integrins. It can be
considered as a stabilized high affinity conformation.

3.4 Discussion
Our simulations results show that TEM8 yields higher binding affinity to PA in the
presence of Mg2+ than Ca2+. The metal ion in MIDAS domain of TEM8 contributes a
large part (26% to 28%) of the binding affinity. The size of metal ion is the major factor
affecting the binding affinity. Smaller metal ions interact more strongly to both protein
molecules in the complex, and result in higher binding affinity. The change in MM/GBSA
interaction energy between metal ion and PA is larger than the change in total binding
free energy. Residues around the metal ion compensate part of the change in binding
affinity resulted from metal ion. Four salt bridges and three hydrophobic insertions also
contribute a large part of the binding affinity. The interactions are different from the
structural alignment study in 2010 29. The conformation of TEM8 is confirmed as “open”,
and is stabilized in “open”.
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In experiments, we note that TEM8-PA affinity in the presence of either Mg or Ca,
obtained by SPR, has been previously reported for alternate truncations of soluble TEM8
124,128

. Our Kd values agree with previous studies qualitatively, but are not identical

quantitatively. For example, while our Kd in Mg (3.3 ± 1.1 nM) obtained via SPR is
much lower than previous SPR data obtained by Scobie et al (130 ± 46 nM) 124 and Fu et
al (30 ± 9 nM)

29

. Our measured Kd in Ca (570 ± 170 nM) is two-fold lower than the

Scobie value (1100±41 nM)).

Observed differences may simply reflect different

MIDAS domain truncations.

However, TEM8-PA off-rates are slow (10-4/s, as

measured by Fu et al by SPR and confirmed our own SPR data. Previously reported SPR
values result from short (3-5 min) observation of complex dissociation (when reported),
which could contribute to inaccuracies in the resulting reported Kd values.

3.4.1 Simulation Precision
The calculated difference in TEM8-PA interaction energy in the presence of Mg2+ and
Ca2+ is 2.23±1.29kcal/mol, quantitatively agree with the experimental 2.82±0.14kcal/mol.
The calculated relative interaction energy was averaged over 10 repeats of independent
20ns simulations. Each simulation generates 15ns trajectory for analysis, after discarding
the first 5ns as pre-equilibration phase. We calculated the MM/GBSA energy over 15ns
trajectory to average the fast motion. The fast motions are considered to be dominated by
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the motion of small domains, and typically have vibration period between 5-8ns in NMR
experiments97.

The Generalized Born term moderated the overestimated fluctuation in Columbic energy.
An anomalous standard error of more than 3kcal/mol was observed in the Columbic
interaction energy, much larger than the ~1kcal/mol in total electrostatic interaction
energy (Columbic plus GB). The standard error comes from the strong fluctuation in
Columbic interaction energy of the residues formed salt bridges between the two proteins
(e.g. K111, E122, E125 on TEM8). The fluctuation is a result of lack of screening term
for the Columbic interaction energy, because the energy was calculated in vacuum, but
the simulation was conducted in TIP3 explicit solvent. GB term mimics the screening
effect of solvent and, as a result, partially cancels the exaggerated error in Columbic
energy.

3.4.2 The Size of Metal Ion Matters
The size of metal ion leads to the major difference in binding affinity in the presence of
Mg2+ and Ca2+. Ca2+ has a larger ion radius than Mg2+. Larger ion radius leads to larger
distance between metal ion and the other residues in MIDAS. When the distance
increased, vdW, Columbic and Generalized Born interaction energies become weaker,
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according to their definitions. Similar results were found in quantum mechanical study135,
interaction between metal ions have 2 positive charges and residues on MIDAS are
ranked as Mg2+>Zn2+>Ca2+, the ion radius of Zn2+ is between Ca2+and Mg2+. When
expanded to PA-TEM8 complex, smaller metal ion interacts stronger to both proteins in
the complex, and results in higher binding affinity.

Similar to TEM8, many integrin α I domains, remain in a low affinity “closed” state

136

the presence of Ca2+. In integrin αL, the size of the metal ion was shown to affects the
conformation of MIDAS domain137. Based on the relatively lower experimental and
theoretical binding affinity of TEM8 containing Ca2+ in MIDAS, plus the locally
unfolding results from the substitution of metal ion, we suggest that TEM8, analogous to
the closely related integrin αL, can possibly retain a low affinity conformation when Ca2+
is the ion in MIDAS pocket, which is slightly different from the high affinity
conformation.

When the metal ion was stripped out, integrin αL suffers a moderate conformation change
around the MIDAS domain, and lose most of the binding affinity towards ligand
Experiments show that TEM8 lost binding affinity to PA in EDTA solution

24

138

.

. An

unfolding in MIDAS domain was observed after the metal ion from MIDAS was
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removed in free TEM8 simulation.

We suspect that TEM8 may have a different conformation in the presence of Ca2+ or no
metal ion in MIDAS. The possible conformation change can cause larger difference in
binding free energy in the presence of difference metal ions, in addition to the
MM/GBSA interaction energy. To confirm the hypodissertation, results from future NMR
or crystallization structural study on TEM8 in Ca2+ or EDTA/EGTA can serve as
powerful evidences.

Replacing metal ion itself would have changed the interaction energy between TEM8 and
PA by 6.13kcal/mol (Table 3.2), regardless the energy change on the other residues. It is
3.90kcal/mol more than the difference in total binding affinity. As shown in Figure 3.3,
residues on the MIDAS interact more strongly to PA when Ca2+ is in the pocket. They
partially compensated the lost in interaction energy resulted from replacing metal ion.
Hence, when calculating the relative binding affinity, it is necessary to calculate the
energy of all the residues on the same binding pocket, not only the mutated residue or
atoms.
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3.4.3 Large Contact Area Leads to Tight Binding
The 4 salt bridges and 3 hydrophobic insertions in the 2200Å2 buried surface area are
responsible for the strong binding affinity. TEM8 K51, R88, K111 and E122/E125 form
salt bridges with PA E654, D658, E650 and R344, respectively. Different than the strong
interaction between TEM8 K51, R88, K111 and PA (Table S3.1), TEM8 E122/E125
shows much weaker interaction to PA. In PA-CMG2 crystal structure

25

, CMG2 E122

forms a salt bridge with PA R344. When pH is decreased, the CMG2 E122 drift away
from R344 after 2.6ns of MD simulation
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. Similar phenomena were observed in our

PA-TEM8 simulation at pH=7. Further, TEM8 E125 can also form salt bridge with PA
R344, competing with PA E122. E122 is considered as the base of ligand binding for
CMG2. Hence, pH may affect the binding preference of PA towards CMG2 and TEM8.
The stability of this salt bridge and the possibility for PA R344 to form salt bridge with
other residues still need further investigation.

TEM8 loop α2-α3 and loop β2-β3 contributes a large portion of the interaction energy
(Figure 3.4). Mutating residue in this domain to another similar residue is not likely to
affect the binding affinity 29. In addition to the buried surface area, the 4 salt bridges and
3 hydrophobic insertions are responsible for the binding. Mutations on residues that
formed salt bridges or hydrophobic insertions e.g. K51A, R88Q, E122A, Y119H, show
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big impact to the interaction energy, in terms of IC50

29

. L56 on α1-β1 has attractive

interaction with PA (Table S3.1). V55 and H57 on the same loop also show attractive
interaction, but slightly weaker. L56A mutation exhibits 10 times better IC 50 without
affecting the pH threshold for pore formation. It suggests that L56A mutation decreases
the distance betweenα1-β1 loop and PA, thus allows local residues to contribute stronger
interaction energy.

3.4.4 TEM8 Adopts a Stabilized Open Conformation
TEM8 extracellular vWA domain (3N2N,A29) shows high similarity with integrin alpha I
domains in open conformations. It has Cα atoms RMSD of 2.81Å to integrin αL (PDB ID
1MQ9
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), 3.18 Å to integrin αM (PDB ID 1IDO

139

), 2.71 Å to integrin αX (PDB ID

1N3Y 140), 2.75 Å to integrin α1 (PDB ID 1QCY 141), 2.81 Å to integrin α2 (PDB ID 1DZI
142

), although they have low sequence identity (13%-20%). The integrin I domains have

two possible conformations. They are open and closed conformations (Figure 3.6A),
representing the active and inactive states, respectively136,12. In the closed conformation,
integrins are more stable than in the open conformation. The key-like residue
(phenylalanine or glutamate acid, orange residue in Figure 3.6A) inserts into the
hydrophobic lock near C-terminal (orange cluster in Figure 3.6A). In the open
conformation, the key like residue is pulled out of the hydrophobic lock, and the structure
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becomes less stable. The hydrophobic lock is formed by a valine (or leucine for integrin
αL) and a leucine in integrins. In TEM8 and CMG2, the sequence distance between the
valine and the leucine is one amino acid further. As shown in the crystal structure we
have for TEM8, the hydrophobic pocket in not well formed. It makes TEM8 less possible
to be stabilized in a closed conformation.

F205 on TEM8 interacts to the surrounding protein and solvent molecules similarly to
“closed” conformation integrins. Although the activity and conformation of TEM8 can be
considered as “open” conformation

29

, the hydrophobic ratchet pocket controlling

conformation change has 28.33 Å2 solvent accessible surface area, much smaller than
161.95 Å2 and 53.28 Å2 for “open” conformation integrins. It is also more stable in terms
of energies, 9.63 kcal/mol comparing to 20.75 kcal/mol and 18.55 kcal/mol for “open”
conformation integrins. Unlike the highly buried in “closed” integrins or largely exposed
in “open” integrins, F205 in TEM8 is partially buried on the protein surface. Thus, the
F205W mutation did not make significant change in TEM8 conformation

128

. It is still

possible that TEM8 has a “closed” conformation. However, because the TEM8 “open”
conformation is more stabilized comparing to integrin “open” conformation, TEM8 is not
likely to change to its “closed” conformation spontaneously.
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Integrin Starting Res
aL
288
I
aM
298
Q
aX
296
K
a1
313
N
a2
314
N
TEM8
201
V
CMG2
199
V

L
V
V
V
V
N
K

D
N
E
S
S
D
G

T
N
D
D
D
G
G

F
F
F
E
E
F
F

E
E
D
L
A
Q
Q

K
A
A
A
A
A
A

C Terminal residues
L K D L F T E L Q
L K T I QNQ L R
L K D I QNQ L K
L V T I V K T L G
L L E K A G T L G
L QG I I H
L K G I I

K
E
E
E
E

K
K
K
R
Q

I
I
I
I
I

Y
F
F
F
F

V
A
A
A
S

I
I
I
L
I

E
E
E
E
E

Table 3.6 Residues on integrins and ANTRX coordinate conformational change.

An RMSD of 2.1Å was observed in 10 repeats of 20ns free TEM8 simulation, comparing
to the initial structure. According to NMR experimental study
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, 20ns is sufficient for

protein fast motions, such as the fluctuation of side chains and loops. It is not as powerful
to predict the movement of large domains. Although structural change on the dimension
of domains was not observed, it may still happen in longer simulation.

3.5 Conclusion
Both experimental and simulation data point out TEM8 binds to PA better in the presence
of Mg2+ than Ca2+. Because Mg2+ is smaller in size, it interacts with PA, TEM8 and the
coordinate water molecules more strongly than Ca2+, and leads to higher binding affinity.
Introducing Ca2+ to Mg2+ solution does not affect the binding affinity. It indicates Mg2+
interacts more strongly to TEM8, in either free TEM8 or TEM8-PA complex, than Ca2+.
On the other hand, the residues around the metal ion partially compensate the change in
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interaction energy by interacting more strongly to PA when Ca2+ is in MIDAS. Other than
the metal ion, residues on the buried surface area contribute almost all the interaction
energy.

We suggest the existence of a low affinity conformation of TEM8 in the presence of Ca 2+
in MIDAS and a locally unfolded conformation in the absence of metal ion. Limited by
the simulation time scale, large domain motion or conformation change was not observed
in the simulation. Future structural study can provide more evidence to confirm the
hypodissertation.

TEM8 stays in a stabilized open conformation. Although the overall backbone structure,
binding affinity and the conformation of F205 all indicate TEM8 is in an open
conformation, the SASA and energy penalty of F205 suggest the conformation is
stabilized. TEM8 may still have a closed conformation, but, unlike integrins, it may not
change to closed conformation spontaneously.

Loud thermo noise comes with the large contact surface area and strong interaction.
Adding GBSA terms into traditional MM (vdw and Coulombic energies) reduced the
standard deviation in interaction energy by 70%. With the help of MM/GBSA method, it
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is less expensive to obtain 1kcal/mol precision for protein-protein interaction energy
calculation.

3.6 Appendix

Figure S3.1 Interaction energy contributed by individual residues. (a) Residues on PA contribute most (top
15) to the interaction energy. (b) Residues on TEM8 contribute most (top 10) to the interaction energy.
Error bars show standard error of the mean from 10 individual 20ns MD simulations.
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CHAPTER 4

FIND THE DIFFERENCES FROM SIMILARITY: THE DISTINCT INTERACTION
MECHANISM OF ANTHRAX RECEPTORS CMG2/TEM8

ABSTRACT
Other than the anthrax toxin receptor TEM8, which is over-expression during tumor
angiogenesis, of the receptors, capillary morphogenesis gene 2 (CMG2), is reported to be
a angiogenesis regulation protein widely distributed in human tissues. The two receptors
are structurally highly similar to each other, but are responsible for distinct human
diseases. To facilitate the development of drugs specific to either CMG2 or TEM8, we
examine the differences in mechanism between CMG2 and TEM8 bind to PA. We
estimated the interaction energy between PA and CMG2 using computer simulation
methods, and compared with our previous study of PA-TEM8 binding. In addition, the
calculated relative dissociation constant between CMG2 and PA in the presence of
different divalent metal ions was verified via SPR. Consistent with our experimental
study, computational results indicate CMG2 binds to PA on a significantly higher affinity,
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and the binding is tighter in the present of Mg2+ than Ca2+. Further, computational
analyses suggest that the differences in CMG2-PA and TEM8-PA binding affinity are
mainly due to the differences in α4 helices in CMG2 and TEM8, plus contribution from
the difference in other residues on the contact surface. Specifically, we found PA domain
2 has a strong preference to CMG2 than to TEM8. The correlated motion between CMG2
and PA domain 2 was not found in TEM8-PA interaction. Thus, there may exist distinct
signaling pathways in CMG2-PA binding and TEM8-PA binding.
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4.1 Introduction
Anthrax infection begins from the contact of anthrax protective antigen (PA) and its cell
surface receptors. The two known receptors tumor endothelial marker 8 (TEM8,
ANTRX1) and capillary morphogenesis gene 2 (CMG2, ANTRX2) form a toxin pore
upon binding with PA that transmits the anthrax lethal factor and edema factor into cells 9.
The extracellular von Willebrand Factor A domains of two receptors (TEM8 splice
variant 1 and CMG2-489) are structurally high similar to each other (58% identities, 78%
positives, BLAST2143, 1.2Å RMSD)11 with a fully conserved metal ion dependent
adhesive site29. Previous study [cite PA-TEM8 ion study] shown that they possibly bind
to PA through similar binding surface. The loops on the binding contact surface of TEM8
and CMG2 share 48% identities and 76% of similarities. Although the exact
physiological functions of TEM8 and CMG2 are not known yet, they are known to
regulate the angiogenesis process or the growth of new blood vessels144. Malfunctioning
angiogenesis causes many pathological processes including metastasis, tumor growth and
proliferative retinal diseases, as a consequence of defective TEM8145 or CMG220.

TEM8, according to its name “tumor endothelial marker 8”, is overexpressed in
malignant tumor endothelium rather than normal endothelium16,116. It has been confirmed
that clinical results in cancer vaccines are correlated to TEM-8 expression levels146. For
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tumor cells147,148 and other cell types149,150 outside the vasculature, the distribution of
TEM8 is well established. In tumor vasculature, the expression of TEM8 was also tested
under the impaction of a good number of potential anti-tumorigenic therapeutics, not
including anthrax toxin. Most TEM88 targeted anti-angiogenic therapies combine an
anti-TEM8 antibody with truncated tissue factor to create a fusion protein. The fusion
protein can localize at tumor blood vessels and promote local thrombosis, thus disrupt
tumor vasculature and reduce tumor volume. On the other hand, CMG2 is not
overexpressed in tumor endothelium comparing to TEM8. The mutation and defection of
CMG2 are shown to be linked to infantile systemic hyalinosis (ISH)20, juvenile hyaline
fibromatosis (JHF) and breast cancer151.

Protective antigen based anti-angiogenesis therapies targeting TEM8 is being developed
as anti-cancer agents152,153. Naturally, PA binds to CMG2 at 100~1000 folds higher
affinity than to TEM8124 with the presence of Mg2+ cation in MIDAS. Experiments
showed that mutations in PA domain 4 are able to alter the binding affinity to anthrax
receptors154,155.

Furthermore, PAD7 variant (R659S/M662R) binds preferentially to

TEM8 rather than CMG2 resulting 10 times better EC50152. However, the selectivity
still needs to be improved to be considered for therapy purpose.
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Crystal structure of PA-CMG2 bound complex showed that PA binds to CMG2 through
its domain 2 and 425. Benefiting from the high structural similarity between TEM829 and
CMG211, plus the previous simulation results (Chapter 3), we believe TEM8 binds to PA
via similar binding site. Alanine scanning154 and simulation study identified the “hot
spots”134 on PA for the binding were loop 680-688, loop 652-658 and loop 340-344.
However, the preference between TEM8 and CMG2 of these loops and the individual
residues on the loops has not yet been investigated.

To further identify the “hot spots” on PA for PA-TEM8/CMG2 binding, we employed
homology modeling method to build conformation of PA-TEM8 bound complex, and did
simulation to identify the contribution to binding free energy by each individual residue
on PA in PA-TEM8 and PA-CMG2 binding. We found loop 652-658 on domain 4 prefers
CMG2, whereas, loop 340-344 prefers TEM8. We also simulated the binding mechanism
of PA binding to TEM8 in the presence of Ca2+ or Mg2+ cation in MIDAS. Ultimately,
our simulation binding free energy agrees with surface plasmon resonance experiment
results.

4.2 Method
We used the crystal structure of PA-CMG2 complex (PDB: 1T6B11) as the initial
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structure for MD simulation. Missing loops in PA far (more than 14Å) from the binding
surface were patched using the optimized conformation generated by Modeller9.1181.

PA domain I and III were truncated in the simulation to improve efficiency using a similar
to the simulation method used in Chapter 3. We consider the truncation will also not
significantly affect the binding interaction energy in PA-CMG2. 1kcal•mol-1 harmonic
restraints were applied on the residues more than 14 Å away from the binding surface in
MD simulation to prevent unwanted conformation change. Detailed reasons were
explained in section 2.2.3. To study the effect of different metal ions, we replaced the
Mg2+ with Ca2+, and set the initial coordinate as the same as Mg2+.

Energy minimizations and Molecular Dynamics simulations were conducted under the
condition as mentioned in Chapter 3. A total of 10 repeats of 20ns MD simulation
trajectory were generated using different initial velocities. The first 5ns of MD simulation
trajectories were considered as equilibration phase, the last 15ns were used in further
analysis.

MM/GBSA interaction free energy and per residue interaction energy decomposition
were also conducted under the same condition as mentioned in Chapter 3. For the same
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reason as in Chapter 3, the configurational entropies were not included in the interaction
free energy.

Similarity and identity of residues on CMG2 and TEM8 were obtained using blast2seq143
and TOPMATCH80. Because CMG2 (chain Y of PDB: 1T6B) has fewer residue than
TEM8 (chain A of PDB: 3N2N), CMG2 residues are aligned according to the residue
numbers of TEM8.

4.3 Result and Discussion
To find the differences in the binding mechanism between PA-CMG2 binding and
PA-TEM8 binding, we calculated the interaction energy of PA-CMG2 binding and
decomposed the interaction free energy into per-residue contribution. The per-residue
contribution of PA and CMG2/TEM8 are investigated in details. Furthermore, we also
investigated how the replacement of MIDAS metal ion influents the binding.

4.3.1 CMG2 binds to PA stronger than TEM8
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MM/GBSA Interaction Energy

Protein
ΔEele
ΔEvdw
ΔGSA
ΔGGB
ΔGcal.
ΔGexp
CMG2 -185.31±3.42 -74.04±0.92 -13.94±0.10 163.17±2.72 -110.12±0.87 -14.05±0.08
TEM8
-28.65±3.78 -68.75±0.63 -13.49±0.10 7.13±3.01 -103.76±0.94 -12.82±0.10
Table 4.1 Experimental and calculated MM/GBSA interaction energy between CMG2/TEM8 and PA in the
presence of Mg2+ ion in MIDAS. Etot is total MM/GBSA interaction energy; EvDW is the van der Waals
interaction energy; Eelec is the Coulombic interaction energy; EGB is the generalized Born interaction energy;
ESASA is the solvent accessible surface area interaction energy. Values are differences ± standard error.
Standard errors are calculated from 10 repeats of 20ns simulation.

The MM/GBSA interaction free energy between CMG2 and PA is compared with the
binding free energy converted from the dissociation constant measured experimentally by
SPR in the presence of Mg2+. Corresponding catiosn were placed in MIDAS domain in
simulation models. As shown in Table 4.1, experiments showed CMG2 bound to PA in
the presence of Mg2+ 6.36kcal·mol-1 stronger than in the presence of Ca2+. Simulation
data shows a difference of 1.23 kcal·mol-1, matches with experimental results
quantitatively.

Stronger Coulombic interaction (ΔEele) was observed in PA-CMG2 binding comparing
PA-TEM8. If we add it up with the screening term (ΔEGB), the total electrostatic
interaction energy of PA-CMG2 binding equals to -22.14 kcal/mol, is still stronger than
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the -21.52 kcal/mol for PA-TEM8 binding. Stronger van der Waals interactions were
observed in the PA-CMG2 binding, which leads to the major difference. This may
indicate that most of the salt bridges were conserved in PA-CMG2 interaction, with an
addition of some hydrophobic binding pockets comparing to PA-TEM8 binding.

4.3.2 α4 helix and S113/L113 differ the CMG2/TEM8-PA binding affinity
To further investigate the reason of the difference in binding interaction free energy
between CMG2 and TEM8, we calculated the binding interaction free energy contributed
by individual residues on CMG2 and TEM8 (Figure 4.1, Table 4.2). The residues
contributed to the difference in binding free energy to PA are mainly located close to the
contact surface with PA.

α4 helix (residue 150-158 on CMG2, 152-160 on TEM8) that interacts mainly with PA
domain 4 makes CMG2 interact with PA more strongly. The decomposed energy terms in
Table 4.2 shows an extremely more unfavorable Coulombic interaction between TEM8
ASP156, GLU 155 and PA, though the electrostatic screening term cancels most of the
difference. On the same spot, CMG2 LEU154, GLY153 have much stronger van der
Waals interaction with PA. TYR158 on CMG2 also have stronger van der Waals
interaction with PA than TYR160 on TEM8. To further examine the reason, the residues
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on CMG2/TEM8 α4 helices are listed in Table 4.3, and the residues on the PA domain 2
loops close to the α4 helices are listed in Table 4.4. The α4 helix in CMG2 and the nearby
loops in PA domain 2 both have neutral charge, whereas, the α4 helix in TEM8 has a total
charge of negative 3. The negatively charged α4 helix in TEM8 is less favored by PA
domain 2 comparing to the charge neutral helix in CMG2.

SER87, GLN88 in CMG2 show weaker interaction free energy towards PA comparing to
THR87, ARG88 in TEM8, which form salt bridges with residues on PA (Chapter 3). The
distinct Coulombic interactions between GLN88 in CMG2 and ARG88 in TEM8, plus the
less difference in generalized Born screening term together indicate the loss of a salt
bridge in CMG2-PA interaction. The loss in Coulombic interactions is partially
compensated by the gain in vdW interactions. The difference in SER87/THR87 is mainly
from vdW interactions, which roughly cancels the gain in vdW interaction of GLN88. In
all, the difference in SER87/THR87 and GLN88/ARG88 is mainly electrostatics
interaction energy.

Another spot that raises major difference locates in α2-α3 loop in CMG2/TEM8, SER113
and VAL 115 were found in TEM8, LEU113 and GLY115 in CMG2. If we consider the
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sequence of the entire loop 112-118, TEM8 has VSPVGET, CMG2 has VLPGGDT. The
change from SER113 in TEM8 to LEU113 in CMG2 decreased the contribution to
binding affinity by 6.78kcal/mol, mainly vdW interaction energy. Interestingly, the
change from VAL115 in TEM8 to GLY115 in CMG2 compensates the loss by
5.01kcal/mol. These two changes are the largest difference in per residue interaction free
energy contribution when compared CMG2 with TEM8. Considering the flexibility of
glycine and the larger size of leucine versus serine, LEU113 leads to a further distance
between the loop in CMG2 and PA, hence weaker vdW interaction energy; whereas, the
combination of SER113 and VAL115 in TEM8 loop allows a smaller distance between
the contact surfaces and stronger interaction energy.

TYR119 on both CMG2 and TEM8 inserts into the hydrophobic pocket between PA
domain 2 and domain 4. Although the interaction free energy of this insertion makes
CMG2 binds more strongly to PA, it is not considered as one of the residues actually
contribute the difference because of the large standard error of the interaction free energy
of this insertion (1.07±0.90 kcal/mol in Table 4.2). The standard error in the per residue
free energy contribution of ARG111/LYS111 is also comparable to the difference in
energy. Thus, TYR119/TYR119 and ARG111/LYS111 were not considered as factors that
have changed the binding affinity.
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Thus, the difference in CMG2/TEM8 binding affinity towards PA is mainly caused by the
difference in α4 helix, S113/L113, G115/V115, GLN88/ARG88, SER87/THR87. Most of
the difference in affinity is caused by the different charges on α4 helix. Experiments have
shown that mutating LEU56 in TEM8 using the corresponding ALA56 in CMG2 can
improve TEM8-PA binding29. We haven't found evidence to explain such finding. We
predict that mutations on TEM8 that neutralized the negative total charge may enhance
the binding between TEM8 and PA; S113L mutation on CMG2 may enhance CMG2-PA
binding.
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Figure 4.1 The colors for residues show the difference in MM/GBSA interaction energy between PA and
individual residues on CMG2/TEM8. The unmarked grey protein in the upper part represents PA. The white
protein on the bottom part represents CMG2/TEM8. Residue name and numbers are marked by name and
number in CMG2/TEM8. Positive energies mean CMG2 residue interacts more strongly to PA; negative
energy values mean the corresponding residues on TEM8 interact more strongly.
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Difference in MM/GBSA interaction energy between
PA and individual residues on TEM8/CMG2(ETEM8-ECMG2)
CMG2/TEM8 Residue
Stronger in TEM8
SER113/LEU113
GLN88/ARG88
ALA56/LEU56
SER87/THR87
Stronger in CMG2
VAL115/GLY115
LEU154/ASP156
ARG111/LYS111
TYR158/TYR160
GLY153/GLU155
GLU117/ASP117
TYR119/TYR119

ΔEtot

ΔEvDW

ΔEelec

ΔEGB

ΔESASA

-6.78±0.62
-2.38±1.14
-1.74±0.41
-1.51±0.60

-6.66±0.61
1.52±0.96
-1.60±0.39
-1.17±0.55

0.97±0.19
-54.55±2.82
-0.04±0.09
-0.14±0.51

-0.68±0.17
50.68±1.34
0.06±0.07
-0.06±0.50

-0.41±0.03
-0.03±0.05
-0.17±0.03
-0.13±0.01

5.01±0.26
4.35±0.73
2.88±2.62
2.88±1.33
2.87±0.21
1.50±1.12
1.07±0.90

4.35±0.26
3.08±0.51
0.09±1.50
2.97±1.25
2.29±0.16
0.73±0.48
1.22±0.59

0.27±0.16
23.63±1.43
-1.30±10.31
0.23±0.35
19.58±0.45
4.16±1.62
-0.10±0.50

-0.05±0.13
-22.58±1.05
3.96±6.71
-0.41±0.15
-19.19±0.42
-3.46±1.54
-0.08±0.28

0.45±0.01
0.22±0.04
0.13±0.12
0.09±0.06
0.19±0.02
0.08±0.02
0.02±0.04

Table 4.2 Residues on CMG2 and corresponding residues in TEM8 with difference in MM/GBSA
interaction energy between the residue and PA greater than 1kcal/mol. Negative energy values indicate the
residues on CMG2 interact with PA more strongly; positive energies indicate the corresponding residues on
TEM8 interact with PA more strongly. Etot is total MM/GBSA interaction energy; EvdW is the van der Waals
interaction energy; Eelec is the Coulombic interaction energy; EGB is the generalized Born interaction energy;
ESASA is the solvent accessible surface area interaction energy. Values are differences ± standard error.
Standard errors are calculated from 10 repeats of 20ns simulation.
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Residues on α4 helices of CMG2 and
TEM8
CMG2 Charge TEM8
Charge
LYS150
+1
GLU152
-1
LEU151
0
LEU153
0
ASP152
-1
HIS154
0
GLY153
0
GLU155
-1
LEU154
0
ASP156
-1
VAL155
0
LEU157
0
PRO156
0
PHE158
0
SER157
0
PHE159
0
TYR158
0
TYR160
0
Total
0
Total
-3
Table 4.3 Residue names and their charges on α4 loops of CMG2 and TEM8.

Residues on PA
domain 2 loops on
Residue
Charge
LEU338
0
SER339
0
LEU340
0
ALA341
0
GLY342
0
GLU343
-1
ARG344
+1
THR345
0
TRP346
0
ALA347
0
Table 4.4 Residue names and their charges on PA domain 2 loops on contact surface with CMG2 and
TEM8.
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4.3.3 CMG2 binds tighter to PA domain2 than TEM8
Residues on protective antigen show distinct preferences between CMG2 and TEM8. PA
binds to CMG2 and TEM8 though its domain 2 and 4. Table 4.5 shows that PA binds to
CMG2 and TEM8 mainly through domain 4. PA domain 4 interacts with CMG2 at
4.08kcal/mol more than towards TEM8, considering the 85-90kcal/mol total, it’s about 5%
differences. PA domain 2 interacts with CMG2 and TEM8 less strongly than its domain 4,
but the difference in binding free energy is 13.36kcal/mol, it is more than 50% of the
24.97 kcal/mol energy between TEM8 and PA domain 2. Hence, PA domain 2 binds to
CMG2 more strongly, and PA domain 4 binds to TEM8 more strongly.

If we decompose the energy into different terms, van der Waals interaction contributes
10.20kcal/mol of the 13.66kcal/mol difference in domain 2 and 5.39kcal/mol of the
4.08kcal/mol difference in domain 4. The summation of Coulombic and generalized Born
interaction energy can be considered as the electrostatic energy. It raises 2.68kcal/mol
difference for domain 2 and partially cancels the difference in vdW energy by
1.65kcal/mol for domain 4.The rest of the difference is from SASA energy. Thus, the
majority of the difference in binding free energy results from vdW interaction energy.

In PA domain 2, loop 340-344 is responsible for 12.12kcal/mol in the 13.66kcal/mol
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difference in interaction free energy between PA domain 2 and CMG2/TEM8. The two
charged residues, GLU343 and ARG 344 composed the neutral charge on this loop (Table
4.6). When bound with the neutrally charged CMG2 loops and negatively charged (-3)
TEM8 loops, the electrostatic (Coulombic and generalized Born) energies on these two
residues are more favorable towards CMG2. For interaction energy between each residue
in this loop and PA, vdW interaction energies are stronger in PA-CMG2 complex. This
observation confirms that the negatively charged loop 152-160 in TEM8 in less favored
by PA domain 2.

In PA domain 4, the difference in binding free is mainly contributed by the residues on
loop 652-658 (Table 4.6). Because of the large standard error in the energies of GLU654
and ASP 658, the differences caused by these two residues will not be further analyzed.
The difference in LEU652 is mainly from the vdW interaction energy. Considering the
differences in binding free energy cause by residues on TEM8/CMG2 SER113/LEU113
and VAL115/GLY115, this result confirms that the change in TEM8/CMG2 may have
changed the distance between CMG2/TEM8 and PA, furthermore, caused the difference
in interaction energy between PA domain 4 and CMG2/TEM8. This is consistent with the
hydrophobic binding pocket observed in Chapter 3.
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Thus, the different in CMG2/TEM8-PA binding affinity mainly results from the
discrimination from PA domain 2. If PA domain2 can bind to CMG2 or TEM8 without
the other domains, the difference in binding affinity would be larger than using all PA
domains. To enhance the specificity towards CMG2, antibodies can be developed based
on PA domain 2 or the loops on PA domain 2 that bind to CMG2 (340-344).

MM/GBSA interaction energy between PA domains and TEM8/CMG2
Protein Domains
ΔEtot
ΔEvDW
ΔEelec
ΔEGB
TEM8
Domain 2
-24.97±0.74
-20.38±0.75
43.68±6.75
-46.62±2.80
Domain 4
-89.31±1.47
-48.96±0.62
-71.38±15.03 35.56±6.36
CMG2
Domain 2
-38.33±0.51
-30.58±0.39
-38.67±4.18
33.05±1.84
Domain 4
-85.23±1.36
-43.47±0.73 -147.25±12.27 109.78±5.23

ΔESASA
-1.66±0.00
-4.54±0.00
-2.12±0.00
-4.29±0.00

Table 4.5. MM/GBSA interaction energy between CMG2/TEM8 and PA domain 2/4. Etot is total
MM/GBSA interaction energy; E vdW is the van der Waals interaction energy; Eelec is the Coulombic
interaction energy; EGB is the generalized Born interaction energy; E SASA is the solvent accessible surface
area interaction energy. Values are differences ± standard error. Standard errors are calculated from 10
repeats of 20ns simulation.
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Figure 4.2 The colors for residues show the difference in MM/GBSA interaction energy between CMG2
/TEM8 and individual residues on PA. The unmarked grey protein in the lower part represents TEM8 or
CMG2/TEM8. The white proteins on the top part represents protective antigen. Positive energies mean the
PA residue interacts more strongly to CMG2; negative energy values mean the residues interact with TEM8
more strongly.
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Difference in MM/GBSA interaction energy between TEM8/CMG2(E TEM8-ECMG2) and individual
residues on PA
PA Residue
ΔEtot
ΔEvDW
ΔEelec
ΔEGB
ΔESASA
Discriminate TEM8
LEU652
-2.10±0.35
-2.07±0.35
-0.24±0.20
0.40±0.16
-0.19±0.03
GLU654
-1.89±1.62
-0.01±0.94
16.35±5.53
-18.21±3.30 -0.02±0.06
ASP658
-1.27±1.21
0.88±0.66
8.64±3.38
-10.71±1.76 -0.08±0.01
Discriminate CMG2
GLU343
3.51±1.76
1.77±2.09
-26.91±6.13
28.49±3.62
0.16±0.05
GLY342
2.88±0.80
1.42±0.80
3.80±0.18
-2.38±0.17
0.04±0.06
LEU340
2.27±0.64
2.26±0.57
-0.07±0.20
-0.07±0.18
0.15±0.06
ALA341
1.87±0.63
1.69±0.55
0.60±0.20
-0.40±0.13
-0.02±0.02
ARG344
1.73±0.28
1.59±0.31
23.03±1.26
-22.94±1.00 0.05±0.02
Table 4.6 Residues on PA discriminate CMG2 or TEM8 with difference in MM/GBSA interaction energy
between the residue and CMG2/TEM8 greater than 1kcal/mol. Negative energy values indicate the PA
residues interact more strongly to CMG2; positive energies indicate the residues interact more strongly to
TEM8. Etot is total MM/GBSA interaction energy; E vdW is the van der Waals interaction energy; Eelec is the
Coulombic interaction energy; EGB is the generalized Born interaction energy; E SASA is the solvent
accessible surface area interaction energy Values are differences ± standard error. Standard errors are
calculated from 10 repeats of 20ns simulation.
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4.3.4 Correlated motion between CMG2 and PA domain 2
Covariance analysis can identify the correlated motions in protein dynamics in PA-CMG2
and PA-TEM8 complex. The highly correlated motions in groups of residues usually
indicate strong binding or signaling pathway. To further investigate the differences in
PA-CMG2 and PA-TEM8 binding, I analyzed the covariance in the motion of Cα atoms
for each residue in the complex and shown in Figure 4.3.

In both PA-CMG2 and PA-TEM8 complexes, strong correlations were observed in each
local domain of PA domain 2, 4 and CMG2/TEM8. Surprisingly, despite of the strong
interaction free energy between PA domain 4 and CMG2/TEM8, almost no strong
correlation was discovered between them; whereas some strong anti-correlations were
discovered between CMG2/TEM8 and PA domain 2. This indicates the existence of
motions conduction between CMG2/TEM8 and PA domain 2; and PA domain 4 may be
mainly responsible for the binding and recognition.

The difference in covariance between PA-CMG2 and PA-TEM8 lies in the PA domain 2
(sub-figures in Figure 3 A, B). After applying the filter to screen weak correlations below
0.25, strong positive correlations were observed between the PA domain 2 loops near the
contact surface (340-344) and CMG2 residue 118-120, 150-168. However, such
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correlations were not observed for the corresponding residues in PA-TEM8 complex.
Considering the difference in binding interaction energy contributed by PA domain 2 in
PA-CMG2 and PA-TEM8 interactions, the difference in correlated motion could be a
result of the lack of vdW interaction between PA domain 2 and TEM8. This may suggest
TEM8 and CMG2 have distinct signaling pathway when bound with PA.
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Figure 4.3 Correlation in the motion of Cα atoms in each residue of the PA-CMG2/TEM8 complex. PA-D2
is PA domain 2, PA-D4 is PA domain 4.

Residue numbers are labeled in the small windows. A cut off of

0.25 is used to filter out the weakly correlated motions, correlation between -0.25 to 0.25 is not shown in
the figures.
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4.3.4 Metal ion in MIDAS affects PA-CMG2 binding affinity
To measure the binding interaction energy between CMG2 and PA in the presence of
different metal ions, the dissociation constant was calculated in the presence of Mg2+ and
Ca2+ and compared with results from SPR experiments. As shown in Table 4.7, CMG2
binds to PA more strongly in the presence of Mg2+ than in the presence of Ca2+. Both
simulation results and experimental results give the same qualitative results. The structure
of MIDAS is shown in Figure 3.2A.

Stronger electrostatic interaction (ΔEele+ΔGGB) was observed in the presence of Mg2+
comparing to Ca2+. Weaker van der Waals interactions were observed in the presence of
Mg2+. The major difference comes from the Coulombic interaction. On the contrary, the
GB energies do not show much difference. The GB energy mimics the solvation
screening effect to partially cancel out more than 80% of the Coulombic term.
Surprisingly, the GB energy only cancels more 0.6kcal.mol electrostatic energy,
comparing to the 10.4kcal/mol difference in Coulombic energy. It indicates that the
replacement of metal ion affects the interaction between CMG2 and PA more, and less to
the dissolvation process.

The distances between Mg2+ and all the coordinating oxygen atoms are shorter than those
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between Ca2+ and the oxygen atoms (Table 4.8), very similar to the results for TEM8-PA
binding (Figure 3.2C). The results can be also interpreted as Ca2+ expands the size of
MIDAS domain and leads to weaker interactions with residues.

Metal ion

ΔEele

ΔEvdw

ΔGSA

ΔGGB

ΔGcal.

ΔGexp

Mg

2+

-185.31±3.42 -74.04±0.92 -13.94±0.10 163.17±2.72 -110.12±0.87

-14.05±0.08

Ca

2+

-175.73±5.20 -75.99±1.01 -13.76±0.11 162.53±4.37 -102.95±0.95

-13.43±0.03

Table 4.7 Experimental and calculated interaction energies (kcal/mol) for PA-CMG2 binding system. The
standard error was estimated over the mean of 10 repeats, each repeat has 3000 data points. E ele is the
Columbic energy, Evdw is the van der Waals energy, GSA is the non-polar solvation free energy, GGB is the
polar solvation free energy, Gcal is the calculated free energy, Gexp is the experimental free energy.

Metal Ion/
Distance(Å)

ASP344

SER52

SER54

THR118 WATERA WATERB

Mg 2+

1.82±0.01 2.07±0.01 2.09±0.01 2.09±0.01 1.98±0.01

1.93±0.01

2+

2.17±0.01 2.33±0.01 2.33±0.01 2.29±0.01 2.28±0.01

2.25±0.01

Ca

Table. 4.8 Distance between the metal ion in MIDAS and the coordination oxygen atoms in MIDAS
residues.
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CONCLUSION
CMG2 binds to PA better than TEM8 in the present of either Mg2+ or Ca2+ cation. The
stronger binding affinity mainly results from the difference in α4 helices in CMG2 and
TEM8, and also a few differences in residues on the binding surface such as residue 87,
88, 113, 115 on both CMG2 and TEM8. Mutations on these residues could change the
binding affinity, and possibly reverse the specificity of PA to CMG2 and TEM8.

PA domain 2 interacts more strongly towards CMG2 than to TEM8, because of the
neutrally charged α4 helix in CMG2 is more favored by the loops on PA domain 2
binding surface. Based on the difference in affinity, mutations that neutralize the negative
overall charges on TEM8 α4 helix can possibly increase the binding affinity between
TEM8 and PA. On the other hand, PA domain 4 interacts more strongly towards TEM8,
especially that L113/S113-V115/G115 in TEM8/CMG2 contributes the most difference.

The correlated motion between PA domain 2 and CMG2 was not found in TEM8-PA
complex. This may results from the absence of strong interaction between TEM8 and PA
domain 2. If the interaction between CMG2 and PA domain 2 is responsible for signaling
process, such process is possibly missing or differently organized in TEM8 and PA
interaction.
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Hypothesizes of binding affinity in PA and CMG2/TEM8 mutant interaction can be
further confirmed by experiments. The specificity of antibodies targeting CMG2 may be
improved if α4 helix on CMG2 is selected as the binding site. Antibodies targeting the
L113/S113-V115/G115 loop may have the preference towards TEM8.
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APPENDIX
DATASET: TARGETED MD STUDY OF INTEGRIN αM SIGNALING PATHWAY
5.1 Background
Integrins are another group of proteins share the same family with anthrax receptors.
Integrins get their name from their function, which is integrating the extracellular and
intracellular environments. They also bind to signal molecules inside the cells and ligands
outside the cells136. The signaling processes they involve are heavily relied by the immune
system and many other physiology systems156. Integrins are known to have α and β
subunits, which are coupled to in the upstream and downstream signaling pathways157.

More than half of integrin α subunits contain a von Willebrand factor A domain, which
have about 200 amino acid, and are similar to CMG2 and TEM8 mentioned in the
previous chapters. These domains are known as an inserted domain, or I domain. Integrin
α I domain is the major ligand binding site in integrins. Several crystal structures of
independent integrin I domain have been obtains with or without ligand bound to them.
Integrin α I domain binds to their ligands through a highly conserved metal ion dependent
adhesion site (MIDAS). The MIDAS in integrin α I domain is identical to the one in
anthrax receptors. In MIDAS, a divalent metal ion is ligated by five side chains (Figure
5.1).
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Figure 5.1 Structures of the αM I domain MIDAS in closed conformation (a) and open conformation (b).
E314 is from a ligand coordinates with the MIDAS magnesium. Green particles are the divalent metal ions
in MIDAS, and red spheres are oxygen atoms in coordinating water-molecules. [From PDB 1JLM158 and
1IDO159]

Integrin α I domains have been crystallized in three distinct conformations: open,
intermediate, and closed137,160. These conformations demonstrate high, intermediate, and
low binding affinity to their ligands, respectively. The arrangement of MIDAS, β6-α7
loop, and C-terminal loops are believed to be correlated to the change in conformation
and affinity161. The rearrangements of MIDAS in integrin α I domain are accompanied by
a 2.3Å shift away from the metal ion THR209 in open to closed conformation change.
The closed to open conformation change is believed to initiated by the pulling of
C-terminal residues and therefore resulted the rearrangement in MIDAS residues161.
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However, the detailed pathway conformation change has not been found yet.

The displacement of residues on α7 helix, especially PHE302, regulates the critical160
hydrophobic pocket that stabilize the conformation in open or closed. Engineered
disulfide bond introduced to lock the hydrophobic pocket can stabilized the open
conformation137. An engineered intermediate state has been crystallized for integrin αL,
which has the C-terminal in open conformation but MIDAS in closed conformation162.
Steered molecular dynamics studies also showed the existence of intermediate state of
C-terminal in the pathway from close to open conformation127. However, the mechanism
of the hydrophobic pocket has not been investigated in details.

In this data set, we preformed a targeted molecular dynamics to simulate the integrin
conformation process. The sequence of displacement on key residues was measured to
demonstrate the mechanism of conformation regulation. The popularities of open,
intermediate, and closed conformation were calculated to investigate the energy barriers
in the conformation transition process. We also studied the correlated motions in
conformation change to find out the transmission of conformational signals. In addition,
we made mutations on the α7 helix and C-terminals to further confirm the existence of
conformation change in anthrax receptors.
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5.2 Method
5.2.1 Preparation of Complex
The crystal structures of integrin αM in open159 and closed158 were used as initial structure
for molecular dynamics simulation. Different numbers of residues were included in the
crystal structures. For consistency, we truncated the residues that were not shared in these
two crystal structures. The truncated residues are on the C and N terminals, and are not
considered as the residues highly correlated to the binding of conformation changes161.

Mutations on α7 helix and C-terminal were made using the mutation module in
Modeller9.1181. 1000 cycles of energy iteration were conducted to obtain the optimized
structure.

5.2.2 Molecular Dynamics simulation
To minimize the possible errors resulting from truncation, the initial atomic coordinates
of integrin αM I domains were first subjected to an energy minimization in vacuum to
remove energy clashes. The energy minimization has 10 cycles of 1,000 steps, reducing
the harmonic restraint each cycle on all protein atoms from 10 kcal·mol-1·Å-2 to 1
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kcal·mol-1·Å-2 in decrements of 1 kcal·mol-1·Å-2 under Steepest Descent method in
CHARMM 35b6 software package83 and charmm27 force field parameters46. The protein
was then dissolved in a TIP384 water and 0.15mol·L-1 NaCl box of 86Å86Å 86Å at a
mixed density of 0.951g/cm3. Extra chloride anions were used to neutralize the positive
charge of the protein complex.

After the protein solvent was generated, further energy minimization and molecular
dynamics simulations of protein solution were run using NAMD 2.10-GPU software
package85 with charmm27 force field parameters. Two cycles of 10000 steps of
Conjugated Gradient minimization were run NAMD with fixed protein atoms and
without constraints, respectively. Finally, 50 ns of targeted molecular dynamics was
conducted using a spring constant k=200 in an artificial potential

where RMS(t) is the instantaneous best-fit RMS distance of the current coordinates from
the target coordinates, RMS*(t) evolves linearly from the initial RMSD at the first TMD
step to the final RMSD at the last TMD step, and N is the number of targeted atoms. The
structure of closed conformation was used as a target when using open conformation as
initial structure, or vise versa. Temperature was set at 300k with a damping coefficient of
5ps-1 using Langevin dynamics86. Pressure was set at 1 bar using a Langevin-Noose
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Hoover piston87 with a damping time of 50ps-1. Particle Mesh Ewald88 was used to
calculate long-range electrostatic interactions. The time step was set at 2fs with the use of
Rigid Bond algorithm89 between hydrogen atoms and heavy atoms.
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5.3 Result and discussion
5.3.1 Movement of residues regulating conformation change

Figure 5.2 RMSD of MIDAS residue in wild type integrin αM I domain during open to closed
conformation change.
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Figure 5.3 RMSD of C-ternimal residue in wild type integrin αM I domain during open to closed
conformation change.
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Figure 5.4 RMSD of MIDAS residue in wild type integrin αM I domain during closed to open
conformation change.
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Figure 5.5 RMSD of C-terminal residue in wild type integrin αM I domain during closed to open
conformation change.
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5.3.2 The existence of intermediate state

Figure 5.6 Population of conformations during open to closed conformation change of wild type integrin
αM I domain.
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Figure 5.7 Population of conformations during closed to open conformation changeof wild type integrin
αM I domain.
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5.3.3 Correlated motion in conformation change

Figure 5.8 Correlated motion in residues during open to closed conformation change of wild type integrin
αM I domain.
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Figure 5.9 Correlated motion in residues during closed to open conformation change of wild type integrin
αM I domain.
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5.3.4 F302W mutation study

Figure 5.10 Correlated motion in residues during open to closed conformation change of integrin αM I
domain F302W mutant.
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Figure 5.11 Correlated motion in residues during closed to open conformation change of integrin αM I
domain F302W mutant.
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Figure 5.12 Population of conformations during open to closed conformation change of integrin αM I
domain F302W mutant.
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Figure 5.13 Population of conformations during closed to open conformation change of integrin αM I
domain F302W mutant.
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Figure 5.14 RMSD of C-ternimal residue in integrin αM I domain F302W mutant during open to closed
conformation change.
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Figure 5.15 RMSD of C-ternimal residue in integrin αM I domain F302W mutant during closed to open
conformation change.
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5.3.5 TEM8-like mutation study

Figure 5.16 Correlated motion in residues during open to closed conformation change of integrin αM I
domain TEM8-like mutant.
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Figure 5.17 Correlated motion in residues during closed to open conformation change of integrin αM I
domain TEM8-like mutant.
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Figure 5.18 Population of conformations during open to closed conformation change of integrin αM I
domain TEM8-like mutant.
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Figure 5.19 Population of conformations during closed to open conformation change of integrin αM I
domain TEM8-like mutant.
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Figure 5.20 RMSD of C-ternimal residue in integrin αM I domain TEM8-like mutant during open to closed
conformation change.
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Figure 5.21 RMSD of C-ternimal residue in integrin αM I domain TEM8-like mutant during closed to open
conformation change.
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